F 0558
Reasonably accommodate the needs and preferences of each resident.
Level of Harm - Minimal harm
or potential for actual harm
Based on observation, interview, and record review, the facility failed to ensure that the pad call light (a
device with sensitive touch surface ideal for patients who may have difficulty using standard call cord to
signal need for assistance from a professional staff) was within reach for one (1) out of 37 sampled
residents.
Residents Affected - Few
This deficient practice had the potential to result in the resident not being able to call for facility staff
assistance and delay of care and services that can negatively affect resident's comfort and well-being.
Findings:
During a review of Resident 31's admission Record, the admission Record indicated the facility admitted
the resident on 8/9/2024 with diagnoses including but not limited to dementia (a general term for a
condition with loss of memory, language, problem-solving and other thinking abilities that are severe
enough to interfere with daily life), depression (a mood disorder that causes a persistent feeling of sadness
and loss of interest), and mild protein-calorie nutrition (a type of undernutrition when a person does not
consume enough protein and calories which may lead to muscle loss, fat loss, and the body not working as
it usually would).
During a review of Resident 31's History and Physical (H&P) dated 8/10/2024, the H&P indicated the
resident did not have the capacity to understand and make decisions.
During a review of Resident 31's Minimum Data Set (MDS, a federally mandated assessment tool), dated
8/13/2024, the MDS indicated the resident had severely impaired cognition (mental action or process of
acquiring knowledge and understanding) and required partial/moderate assistance with eating, and oral
hygiene, and substantial/maximal with all other activities of daily living (ADLs - basic tasks that must be
accomplished every day for an individual to thrive). The MDS indicated Resident 3 had impairment on both
lower extremities.
During a review of Resident 31's care plan (CP) on risk for falls related to but not limited to balance problem
with standing, balance problem with walking, joint pains, mental status initiated 8/14/2024 with target date
11/10/2024, the CP indicated an intervention to place call light within reach.
During a concurrent observation and interview on 10/1/2024 at 9:37 a.m., inside resident 31's room with the
Director of Nursing (DON), observed Resident 31's call light caught in between the mattress and the right
upper siderail, and not within the resident's reach. The DON stated the call light should have been placed
within Resident 31's reach.
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 48
Event ID:
056168
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
056168
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
10/03/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Granada Hills Convalescent
16123 Chatsworth Ave
Granada Hills, CA 91344
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0558
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
During an interview on 10/4/2024 at 2:00 p.m., with the Director of Nursing (DON), the DON stated
Resident 31's call light should have been within reach of the resident so the resident would be able to call
for assistance and have their needs met.
During a review of the facility's policy and procedure (P&P) titled, Call System, Residents, last reviewed
4/12/2024, the P&P indicated the following:
Each resident is provided with a means to call staff directly for assistance form his/her bed, from
toileting/bathing facilities and from the floor.
The call system remains functional at all times and within reach when the resident is in the room.
Calls for assistance are answered as soon as possible, but no later than five (5) minutes. Urgent requests
for assistance are addressed immediately.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
056168
If continuation sheet
Page 2 of 48
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
056168
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
10/03/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Granada Hills Convalescent
16123 Chatsworth Ave
Granada Hills, CA 91344
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0604
Ensure that each resident is free from the use of physical restraints, unless needed for medical treatment.
Level of Harm - Minimal harm
or potential for actual harm
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** d. During a
review of Resident 15's admission Record (AR), the AR indicated the facility admitted the resident on
4/2/2024, with diagnoses including neurocognitive disorder (decreased mental function due to a medical
disease other than a psychiatric illness) and age-related osteoporosis (weak and brittle bones due to lack
of calcium and Vitamin D).
Residents Affected - Some
During a review of Resident 15's History and Physical (H&P), dated 4/3/2024, the H&P indicated the
resident had the capacity to understand and make decisions.
During a review of Resident 15's Minimum Data Set (MDS, a federally mandated resident assessment tool),
dated 7/7/2024, the MDS indicated the resident had the ability to makes self-understood and understand
others and the resident mostly required substantial to maximal assistance on mobility and activities of daily
living (ADLs, are essential and routine tasks that most young, healthy individuals can perform without
assistance).
During an observation on 10/1/2024, at 9:18 a.m., observed Resident 15 lying in bed with both upper bed
rails (a rail or board along the side of a bed that connects the headboard with the footboard) up and the
right side of the bed placed against the wall.
During a concurrent observation and interview on 10/3/2024, at 9:17 a.m., with Certified Nursing Assistant
1 (CNA 1), inside Resident 15's room, observed Resident 15 lying in the bed with both upper bed rails up
and the right side of the bed placed against the wall. CNA 1 stated placing the bed against the wall can be
a considered a restraint because it restricts the resident's movement by preventing the resident from getting
out from the right side of the bed.
During an interview on 10/3/2024, at 1:10 p.m., with the Director of Nursing (DON), the DON stated there
should have been a physical restraint assessment, a physician's order, a care plan, and an informed
consent from the resident of the resident representative prior to placing the resident's bed against the wall
to ensure resident safety and to honor the resident's right to accept or refuse the treatment.
During A review of the facility's recent policy and procedure (P&P) titled, Use of Restraints, last reviewed on
4/12/2024, the P&P indicated physical restraints are defined as any manual method or physical or
mechanical device, material or equipment attached or adjacent to the resident's body that the individual
cannot remove easily, which restricts freedom of movement or restricts normal access to ones' body. The
definition of a restraint is based on the functional status of the resident and not the device. If the resident
cannot remove a device in the same manner in which the staff applied it given the resident's physical
condition and this restricts his/her typical ability to change position or place, that device is considered as a
restraint. Restraints shall only be used upon the written order of a physician and after obtaining consent
from the resident and/or representative (sponsor). The order shall include the following:
a. The specific reason for the restraint (as it relates to the resident's medical symptom);
b. How the restraint will be used to benefit the resident's medical symptom; and
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
056168
If continuation sheet
Page 3 of 48
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
056168
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
10/03/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Granada Hills Convalescent
16123 Chatsworth Ave
Granada Hills, CA 91344
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0604
c. The type of restraint, and period of time for the use of the restraint.
Level of Harm - Minimal harm
or potential for actual harm
e. During a review of Resident 32's admission Record (AR), the AR indicated the facility admitted the
resident on 7/25/2022, and readmitted the resident on 9/22/2024, with diagnoses including wedge
compression fracture (a common fracture [break in bone] of the spine) of first lumbar vertebra (the topmost
vertebra in the lumbar spine), lack of coordination, and radiculopathy (a condition that occurs when a nerve
root in the spines is compressed or irritated, resulting in a range of symptoms).
Residents Affected - Some
During a review of Resident 32's H&P, dated 9/23/2024, the H&P indicated had the capacity to make
decisions.
During a review of Resident 32's MDS, dated [DATE], the MDS indicated the resident had the ability to
make self-understood and understand others and the resident required substantial to maximal assistance
on mobility and activities of daily living (ADLs).
During an observation on 10/1/2024, at 3:35 p.m., observed Resident 32 lying in bed with both upper bed
rails up and the right side of the bed placed against the wall.
During a concurrent observation and interview on 10/3/2024, at 9:21 a.m., with CNA 1, inside Resident 32's
room, observed Resident 32 lying on the bed with the right side of the bed placed against the wall. CNA 1
stated placing the bed against the wall is considered a restraint because it restricts the resident's
movement by preventing the resident from getting out from the right side of the bed.
During an interview on 10/3/2024, at 1:10 p.m., with the Director of Nursing (DON), the DON stated there
should have been a physical restraint assessment, a physician's order, a care plan, and an informed
consent from the resident of the resident representative prior to placing the resident's bed against the wall
to ensure resident safety and to honor the resident's right to accept or refuse the treatment.
During A review of the facility's recent policy and procedure (P&P) titled, Use of Restraints, last reviewed on
4/12/2024, the P&P indicated physical restraints are defined as any manual method or physical or
mechanical device, material or equipment attached or adjacent to the resident's body that the individual
cannot remove easily, which restricts freedom of movement or restricts normal access to ones' body. The
definition of a restraint is based on the functional status of the resident and not the device. If the resident
cannot remove a device in the same manner in which the staff applied it given the resident's physical
condition and this restricts his/her typical ability to change position or place, that device is considered as a
restraint. Restraints shall only be used upon the written order of a physician and after obtaining consent
from the resident and/or representative (sponsor). The order shall include the following:
a. The specific reason for the restraint (as it relates to the resident's medical symptom);
b. How the restraint will be used to benefit the resident's medical symptom; and
c. The type of restraint, and period of time for the use of the restraint.
f. During a review of Resident 25's admission Record (AR), the AR indicated the facility admitted the
resident on 9/8/2022, with diagnoses of vascular dementia (a chronic condition that occurs when blood flow
to the brain is disrupted, damaging brain tissue and affecting memory, thinking, and
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
056168
If continuation sheet
Page 4 of 48
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
056168
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
10/03/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Granada Hills Convalescent
16123 Chatsworth Ave
Granada Hills, CA 91344
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0604
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
behavior), psychotic disturbance (severe mental disorders that cause abnormal thinking and perceptions),
and depression (a mental health condition that involves a persistent low mood or loss of interest in
activities).
During a review of Resident 25's H&P, dated 9/2/2023, the H&P indicated the resident had the capacity to
understand and make decisions.
During a review of Resident 25's MDS, dated [DATE], the MDS indicated the resident had the ability to
make self-understood and understand others. The MDS indicated the resident required substantial to
maximal assistance on mobility and activities of daily living (ADLs).
During an observation on 10/1/2024, at 9:18 a.m., observed Resident 25 lying in bed with both upper grab
bars raised, and the left side of the bed placed against the wall.
During a concurrent observation and interview on 10/3/2024, at 9:28 a.m., with CNA 1, inside Resident 25's
room, observed Resident 15 lying on the bed with the left side of the bed placed against the wall. CNA 1
stated placing the bed against the wall is considered a restraint because it restricts the resident's
movement by preventing the resident from getting out from the left side of the bed.
During an interview on 10/3/2024, at 1:10 p.m., with the Director of Nursing (DON), the DON stated there
should have been a physical restraint assessment, a physician's order, a care plan, and an informed
consent from the resident of the resident representative prior to placing the resident's bed against the wall
to ensure resident safety and to honor the resident's right to accept or refuse the treatment.
During A review of the facility's recent policy and procedure (P&P) titled, Use of Restraints, last reviewed on
4/12/2024, the P&P indicated physical restraints are defined as any manual method or physical or
mechanical device, material or equipment attached or adjacent to the resident's body that the individual
cannot remove easily, which restricts freedom of movement or restricts normal access to ones' body. The
definition of a restraint is based on the functional status of the resident and not the device. If the resident
cannot remove a device in the same manner in which the staff applied it given the resident's physical
condition and this restricts his/her typical ability to change position or place, that device is considered as a
restraint. Restraints shall only be used upon the written order of a physician and after obtaining consent
from the resident and/or representative (sponsor). The order shall include the following:
a. The specific reason for the restraint (as it relates to the resident's medical symptom);
b. How the restraint will be used to benefit the resident's medical symptom; and
c. The type of restraint, and period of time for the use of the restraint.
Based on observation, interview, and record review the facility failed to ensure residents were treated with
respect and dignity including the right to be free from physical restraints (any manual method, physical or
mechanical device, material or equipment that is attached or adjacent to the resident's body that he or she
cannot easily remove that restricts freedom of movement or normal access to one's body) for six (6) out (9)
sampled residents (Residents 10, 31, 6, 15, 32, and 25) investigated during review of physical restraints
care area by failing to obtain a physician's order, perform an assessment, develop a care plan, and obtain
an informed consent (process in which residents or
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
056168
If continuation sheet
Page 5 of 48
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
056168
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
10/03/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Granada Hills Convalescent
16123 Chatsworth Ave
Granada Hills, CA 91344
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0604
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
resident representatives are given important information, including possible risks and benefits, about a
procedure or treatment) for placement of bed against the wall.
These deficient practices had the potential to result in the restriction of residents' freedom of movement and
violate the resident's rights to be free from any restraints that are imposed for reasons other than the
treatment of the resident's medical symptoms.
Findings:
a. During a review of Resident 10's admission Record, the admission Record indicated the facility admitted
the resident on 7/10/2023 and readmitted the resident on 8/7/2023 with diagnoses including but not limited
to dementia (a progressive state of decline in mental abilities), low back pain, and psychosis (a condition
that happens when a person has trouble telling the difference between what's real and what's not).
During a review of Resident 10's History and Physical (H&P) dated 9/27/2024, the H&P indicated the
resident did not have the capacity to understand and make decisions.
During a review of Resident 10's Minimum Data Set (MDS, a federally mandated resident assessment tool),
dated 8/13/2024, the MDS indicated the resident had severely impaired cognition (mental action or process
of acquiring knowledge and understanding) and required setup/clean-up assistance with eating,
partial/moderate assistance with oral hygiene, upper body dressing, rolling left and right, lying to sitting,
lying to sitting on side of bed, and substantial/maximal with all other activities of daily living (ADLs - basic
tasks that must be accomplished every day for an individual to thrive).
During a review of Resident 10's care plan (CP), there was no CP addressing the placement of the
resident's bed against the wall.
During a review of Resident 10's Order Summary Report, the Order Summary Report did not indicate a
physician's order to place the resident's bed against the wall.
During an observation on 10/1/2024 at 10:16 a.m. inside Resident 10's room, observed resident lying in
bed, with the left side of the bed placed against the wall.
During a concurrent observation and interview on 10/3/2024 at 9:40 a.m. inside Resident 10's room with
Certified Nursing Assistant 1 (CNA 1), CNA 1 stated Resident 10's bed is placed against the wall and both
upper half siderails are up. CNA 1 stated Resident 10 tries to get out of bed unassisted at times and placing
the bed against the wall can be considered a restraint as it restricts the resident's movement by preventing
the resident from getting out of from the left side of the bed.
During an interview on 10/3/24 at 1:10 p.m., with the Director of Nursing (DON), the DON stated placing the
bed against the wall is considered a restraint as it restricts the resident's movement by preventing the
resident from getting out of bed on one side. The DON stated there should have been a physical restraint
assessment, a physician's order, a care plan, and an informed consent from the resident of the resident
representative prior to placing the resident's bed against the wall. The DON stated the purpose of the
informed consent is for the resident and/or resident representative to be aware of the risks and benefits of
placing the bed against the wall and honor their right to consent to or decline the use of a restraint.
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
056168
If continuation sheet
Page 6 of 48
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
056168
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
10/03/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Granada Hills Convalescent
16123 Chatsworth Ave
Granada Hills, CA 91344
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0604
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
During a review of the facility's policy and procedure (P&P) titled, Use of Restraints, last reviewed
4/12/2024, indicated the following:
Physical restraints are defined as any manual method or physical or mechanical device, material or
equipment attached or adjacent to the resident's body that the individual cannot remove easily, which
restricts freedom of movement or restricts normal access to ones' body.
The definition of a restraint is based on the functional status of the resident and not the device. If the
resident cannot remove a device in the same way the staff applied it given the resident's physical condition
and this restricts his/her typical ability to change position or place, that device is considered as a restraint.
Restraints shall only be used upon the written order of a physician and after obtaining consent from the
resident and/or representative (sponsor). The order shall include the following:
a.
The specific reason for the restraint (as it relates to the resident's medical symptom).
b.
How the restraint will be used to benefit the resident's medical symptom.
c.
The type of restraint, and period of time for the use of the restraint.
b. During a review of Resident 31's admission Record, the admission Record indicated the facility admitted
the resident on 8/9/2024 with diagnoses including but not limited to dementia (a progressive state of decline
in mental abilities), depression (a mood disorder that causes a persistent feeling of sadness and loss of
interest), and mild protein-calorie nutrition (a type of undernutrition when a person does not consume
enough protein and calories which may lead to muscle loss, fat loss, and the body not working as it usually
would).
During a review of Resident 31's History and Physical (H&P) dated 8/10/2024, the H&P indicated the
resident did not have the capacity to understand and make decisions.
During a review of Resident 31's Minimum Data Set (MDS, a federally mandated resident assessment tool),
dated 8/13/2024, the MDS indicated the resident had severely impaired cognition (mental action or process
of acquiring knowledge and understanding) and required partial/moderate assistance with eating, and oral
hygiene, and substantial/maximal with all other activities of daily living (ADLs - basic tasks that must be
accomplished every day for an individual to thrive). The MDS indicated Resident 31 had impairment on both
lower extremities.
During a review of Resident 31's care plan (CP), there was no CP addressing the placement of the
resident's bed against the wall.
During a review of Resident 31's Order Summary Report, the Order Summary Report did not indicate a
physician's order to place the bed against the wall.
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
056168
If continuation sheet
Page 7 of 48
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
056168
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
10/03/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Granada Hills Convalescent
16123 Chatsworth Ave
Granada Hills, CA 91344
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0604
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
During an observation on 10/1/2024 at 9:36 a.m. inside Resident 31's room, observed resident lying in bed,
with the left side of the bed placed against the wall.
During a concurrent observation and interview on 10/3/2024 at 9:30 a.m. inside Resident 31's room with
Certified Nursing Assistant 1 (CNA 1), CNA 1 stated Resident 31's bed is placed against the wall and both
upper half siderails are up. CNA 1 stated placing the bed against the wall can be considered a restraint as it
as it restricts the resident's movement by preventing the resident from getting out from the left side of the
bed.
During an interview on 10/3/24 at 1:10 p.m., with the Director of Nursing (DON), the DON stated placing the
bed against the wall is considered a restraint as it restricts the resident's movement by preventing the
resident from getting out of bed on one side. The DON stated there should have been a physical restraint
assessment, a physician's order, a care plan, and an informed consent from the resident of the resident
representative prior to placing the resident's bed against the wall. The DON stated the purpose of the
informed consent is for the resident and/or resident representative to be aware of the risks and benefits of
placing the bed against the wall and honor their right to consent to or decline the use of a restraint.
During a review of the facility's policy and procedure (P&P) titled, Use of Restraints, last reviewed
4/12/2024, indicated the following:
Physical restraints are defined as any manual method or physical or mechanical device, material or
equipment attached or adjacent to the resident's body that the individual cannot remove easily, which
restricts freedom of movement or restricts normal access to ones' body.
The definition of a restraint is based on the functional status of the resident and not the device. If the
resident cannot remove a device in the same way the staff applied it given the resident's physical condition
and this restricts his/her typical ability to change position or place, that device is considered as a restraint.
Restraints shall only be used upon the written order of a physician and after obtaining consent from the
resident and/or representative (sponsor). The order shall include the following:
a.
The specific reason for the restraint (as it relates to the resident's medical symptom).
b.
How the restraint will be used to benefit the resident's medical symptom.
c.
The type of restraint, and period of time for the use of the restraint.
c. During a review of Resident 6's admission Record, the admission Record indicated the facility admitted
the resident on 11/29/2011 and readmitted the resident on 6/7/2022 with diagnoses including but not
limited to dementia (a progressive state of decline in mental abilities), blindness left eye, and schizophrenia
(a mental disorder characterized by delusions [a fixed false belief that
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
056168
If continuation sheet
Page 8 of 48
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
056168
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
10/03/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Granada Hills Convalescent
16123 Chatsworth Ave
Granada Hills, CA 91344
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0604
Level of Harm - Minimal harm
or potential for actual harm
conflicts with reality], hallucinations [sensory experiences that only exist in the mind], disorganized
thoughts, speech and behavior).
During a review of Resident 6's History and Physical (H&P) dated 5/13/2024, the H&P indicated the
resident had fluctuating capacity to understand and make decisions.
Residents Affected - Some
During a review of Resident 6's Minimum Data Set (MDS, a federally mandated resident assessment tool),
dated 8/27/2024, the MDS indicated the resident had severely impaired cognition (mental action or process
of acquiring knowledge and understanding) and required supervision/touching assistance with eating;
partial/moderate assistance with oral hygiene and toileting hygiene, roll left to right, sit to lying, and lying to
sitting onside of bed; substantial/maximal with all other activities of daily living (ADLs - basic tasks that must
be accomplished every day for an individual to thrive). The MDS indicated Resident 6 had impairment on
both lower extremities.
During a review of Resident 6's care plan (CP), there was no CP addressing the placement of the resident's
bed against the wall.
During a review of Resident 6's Order Summary Report, the Order Summary Report did not indicate a
physician's order to place the bed against the wall.
During an observation on 10/1/2024 at 9:46 a.m. inside Resident 6's room with Licensed Vocational Nurse
2 (LVN 2), observed resident lying in bed. The resident's left side of the bed is placed against the wall. LVN
2 stated the bed was placed against the wall because it is the resident's preference.
During a concurrent observation and interview on 10/3/2024 at 9:45 a.m. inside Resident 6's room with
Certified Nursing Assistant 1 (CNA 1), CNA 1 stated Resident 31's bed is placed against the wall and both
upper half siderails are up. CNA 1 stated Resident 6 required assistance in getting out of bed and tries to
get out of bed unassisted at times. CNA 1 stated placing the bed against the wall can be considered a
restraint as it restricts the resident's movement by preventing the resident from getting out from the left side
of the bed.
During an interview on 10/3/24 at 1:10 p.m., with the Director of Nursing (DON), the DON stated placing the
bed against the wall is considered a restraint as it restricts the resident's movement by preventing the
resident from getting out of bed on one side. The DON stated there should have been a physical restraint
assessment, a physician's order, a care plan, and an informed consent from the resident of the resident
representative prior to placing the resident's bed against the wall. The DON stated the purpose of the
informed consent is for the resident and/or resident representative to be aware of the risks and benefits of
placing the bed against the wall and honor their right to consent to or decline the use of a restraint.
During a review of the facility's policy and procedure (P&P) titled, Use of Restraints, last reviewed
4/12/2024, indicated the following:
Physical restraints are defined as any manual method or physical or mechanical device, material or
equipment attached or adjacent to the resident's body that the individual cannot remove easily, which
restricts freedom of movement or restricts normal access to ones' body.
The definition of a restraint is based on the functional status of the resident and not the device.
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
056168
If continuation sheet
Page 9 of 48
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
056168
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
10/03/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Granada Hills Convalescent
16123 Chatsworth Ave
Granada Hills, CA 91344
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0604
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
If the resident cannot remove a device in the same way the staff applied it given the resident's physical
condition and this restricts his/her typical ability to change position or place, that device is considered as a
restraint.
Restraints shall only be used upon the written order of a physician and after obtaining consent from the
resident and/or representative (sponsor). The order shall include the following:
a. The specific reason for the restraint (as it relates to the resident's medical symptom).
b. How the restraint will be used to benefit the resident's medical symptom.
c. The type of restraint, and period of time for the use of the restraint.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
056168
If continuation sheet
Page 10 of 48
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
056168
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
10/03/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Granada Hills Convalescent
16123 Chatsworth Ave
Granada Hills, CA 91344
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0658
Ensure services provided by the nursing facility meet professional standards of quality.
Level of Harm - Minimal harm
or potential for actual harm
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
interview and record review, the facility failed to provide care in accordance with professional standards for
four of four sampled residents (Residents 11, 144, 33, and 28) investigated during review of insulin (a
hormone that lowers the level of glucose [a type of sugar] in the blood) care area by failing to ensure
licensed nurses rotate (a method to ensure repeated injections are not administered in the same area)
subcutaneous (beneath the skin) insulin administration sites.
Residents Affected - Some
The deficient practice had the potential for adverse effect (unwanted, unintended result) of same site
subcutaneous administration of insulin such as lipodystrophy (abnormal distribution of fat) and cutaneous
amyloidosis (is a condition in which clumps of abnormal proteins called amyloids build up in the skin).
Cross Reference F760
Findings:
a. During a review of Resident 11's admission Record (AR), the AR indicated the facility admitted the
resident on 8/12/2024, with diagnoses including type 2 diabetes mellitus (DM2, a chronic disease
characterized by difficulty in blood sugar control and poor wound healing), dysphagia (difficulty swallowing),
and long-term use of insulin.
During a review of Resident 11's History and Physical (H&P), the H&P indicated the resident had the ability
to make his needs known but cannot make medical decisions.
During a review of Resident 11's Minimum Data Set (MDS, a federally mandated resident assessment tool),
the MDS indicated the resident had the ability to make self-understood and understand others. The MDS
indicated the resident receiving hypoglycemic (a class of drugs that help lower blood sugar levels)
medications.
During a review of Resident 11's Order Summary Report, dated 8/12/2024, the report indicated an order for
Humalog Injection Solution 100 units per milliliters (unit/ml, a milliliter is a unit of fluid volume equal to
one-thousandth of a liter) (Insulin Lispro). Inject as per sliding scale (progressive increase in premeal or
nighttime insulin doses): if 150-200= 2 units (the standard amount required for a precise measured activity);
201-250= 4 units; 251-300= 6 units; 301-350= 8 units; 351-400= 10 units call MD if blood sugar (BS)
greater than (>) 400 or less than (<) 60, subcutaneously before meals and at bedtime for DM2.
During a review of Resident 11's Location of Administration Report for Insulin for 8/2024 to 10/2024, the
report indicated Humalog injection solution 100 unit/ml was administered on the following dates and sites:
8/13/2024 at 8:20 p.m. on the Abdomen - Right Upper Quadrant (RUQ)
8/14/2024 at 11:18 a.m. on the Abdomen - RUQ
8/15/2024 at 11:21 a.m. on the Abdomen - Right Lower Quadrant (RLQ)
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
056168
If continuation sheet
Page 11 of 48
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
056168
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
10/03/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Granada Hills Convalescent
16123 Chatsworth Ave
Granada Hills, CA 91344
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0658
8/15/2024 at 9:09 p.m. on the Abdomen - RLQ
Level of Harm - Minimal harm
or potential for actual harm
8/16/2024 at 11:31 a.m. on the Abdomen - RUQ
8/17/2024 at 12:35 p.m. on the Abdomen - RUQ
Residents Affected - Some
8/18/2024 at 5:52 p.m. on the Abdomen - RLQ
8/18/2024 at 8:33 p.m. on the Abdomen - RLQ
8/19/2024 at 4:34 p.m. on the Abdomen - RLQ
8/21/2024 at 12:28 p.m. on the Abdomen - RLQ
8/22/2024 at 11:30 a.m. on the Abdomen - RLQ
8/23/2024 at 10 p.m. on the Abdomen - RLQ
8/25/2024 at 8:15 p.m. on the Abdomen - RLQ
9/10/2024 at 8:12 p.m. on the Abdomen-RLQ
9/16/2024 at 9:28 p.m. on the Abdomen-RLQ
9/29/2024 at 12:41 p.m. on the Abdomen-RLQ
9/29/2024 at 8:22 p.m. on the Abdomen-RLQ
During a concurrent interview and record review on 10/3/2024, at 12:54 p.m., with the Director of Nursing
(DON), reviewed Resident 11's Order Summary Report and Location of Administration Record of insulin
dated 8/2024 to 10/2024. The DON stated there were multiple instances when the licensed nurses did not
rotate the resident's insulin administration sites. The DON stated the licensed nurses should have rotated
the insulin administration sites to prevent discoloration, swelling, and trauma to the skin frequently
administered with insulin.
During a review of the facility's recent policy and procedure (P&P) titled, Insulin Administration, last
reviewed on 4/12/2024, the P&P indicated to provide guidelines for the safe administration of insulin to
residents with diabetes. Select an injection site.
a. Insulin may be injected into the subcutaneous tissue of the upper arm, and the anterior or lateral areas of
the thighs and abdomen. Avoid the area approximately 2 inches around the navel.
b. Injection sites should be rotated, preferably within the same general area (abdomen, thigh, upper arm).
During a review of the facility provided Manufacturer's Guideline on the use of Lispro- Injection, last revised
on 8/2024, the guideline indicated to change the injection site each time to lessen injury under the skin (for
example, pits/lumps or thickened skin).
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
056168
If continuation sheet
Page 12 of 48
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
056168
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
10/03/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Granada Hills Convalescent
16123 Chatsworth Ave
Granada Hills, CA 91344
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0658
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
b. During a review of Resident 144's admission Record (AR), the AR indicated the facility admitted the
resident on 9/25/2024, with diagnoses including type 2 diabetes mellitus, chronic kidney disease (a
long-term condition where the kidneys are damaged and cannot filter blood properly), and long-term use of
insulin.
During a review of Resident 144's H&P, dated 9/27/2024, the H&P indicated the resident did not have the
capacity to make decisions.
During a review of Resident 144's MDS, dated [DATE], the MDS indicated the resident sometimes had the
ability to make self-understood and understand others. The MDS indicated the resident was receiving
hypoglycemic medications.
During a review of Resident 144's Order Summary Report, dated 9/25/2024, the report indicated an order
for Insulin Lispro Injection Solution 100 unit/ml (Insulin Lispro). Inject as per sliding scale: if 151-200= 2
units contact MD for blood sugar less than 70; 201-249= 4 units; 250-300= 6 units; contact MD for blood
sugar above 400, subcutaneously two times a day for DM.
During a review of Resident 144's Location of Administration Report for insulin for 9/2024 to 10/2024, the
report indicated Insulin Lispro Injection Solution 100 unit/ml was administered on the following dates and
sites:
9/29/2024 at 8:22 p.m. on the Abdomen - Left Lower Quadrant (LLQ)
9/30/2024 at 9:24 p.m. on the Abdomen - LLQ
During a concurrent interview and record review on 10/3/2024, at 12:54 p.m., with the DON, reviewed
Resident 144's Order Summary Report and Location of Administration Record of insulin dated 9/2024 to
10/2024. The DON stated there were instances when the licensed nurses did not rotate the resident's
insulin administration sites. The DON stated the licensed nurses should have rotated the insulin
administration sites to prevent discoloration, swelling, and trauma to the skin frequently administered with
insulin.
During a review of the facility's recent policy and procedure (P&P) titled, Insulin Administration, last
reviewed on 4/12/2024, the P&P indicated to provide guidelines for the safe administration of insulin to
residents with diabetes. Select an injection site.
a. Insulin may be injected into the subcutaneous tissue of the upper arm, and the anterior or lateral areas of
the thighs and abdomen. Avoid the area approximately 2 inches around the navel.
b. Injection sites should be rotated, preferably within the same general area (abdomen, thigh, upper arm).
During a review of the facility provided Manufacturer's Guideline on the use of Lispro- Injection, last revised
on 8/2024, the guideline indicated to change the injection site each time to lessen injury under the skin (for
example, pits/lumps or thickened skin).
c. During a review of Resident 33's admission Record, the admission Record indicated the facility admitted
the resident on 3/7/2024 with diagnoses including but not limited to type two diabetes mellitus (DM 2 -a
disorder characterized by difficulty on blood sugar control and poor wound healing) and
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
056168
If continuation sheet
Page 13 of 48
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
056168
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
10/03/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Granada Hills Convalescent
16123 Chatsworth Ave
Granada Hills, CA 91344
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0658
heart failure (a condition that develops when the heart does not pump enough blood to the body's needs).
Level of Harm - Minimal harm
or potential for actual harm
During a review of Resident 33's History and Physical (H&P) dated 3/8/2024, the H&P indicated the
resident had the capacity to understand and make decisions.
Residents Affected - Some
During a review of Resident 33's Minimum Data Set (MDS, a federally mandated resident assessment tool),
dated 9/10/2024, the MDS indicated the resident had moderately impaired cognition (mental action or
process of acquiring knowledge and understanding) and required set up assistance with eating, and oral
hygiene; supervision or touching assistance with rolling left and right; substantial/maximal assistance from
staff with all other activities of daily living (ADLs - basic tasks that must be accomplished every day for an
individual to thrive). The MDS indicated Resident 33 received insulin.
During a review of Resident 33's Order Summary Report, the Order Summary Report indicated the
following physician's order dated 3/7/2024:
Humalog injection solution (insulin lispro) [a hormone that works by lowering levels of sugar in the blood; a
fast-acting insulin that starts to work about 15 minutes after injection, peaks in about 1 hour, and keeps
working for 2 to 4 hours] inject as per sliding scale: if 150 - 200 = 2 units ( a unit of measurement); 201 250 = 4 units; 251 - 300 = 6 units; 301 - 350 = 8 units; 351 - 400 = 10 units. Call physician for blood sugar
less than (<) 60 or more than (>) 400, subcutaneously (SQ) before meals and at bedtime for DM 2.
During a review of Resident 33's Medication Administration Record (MAR) from 7/2024 to 9/2024, the MAR
indicated Humalog injection solution was administered as follows:
07/03/24 9:00 p.m. 07/03/24 8:12 p.m. SQ Abdomen - left lower quadrant (LLQ)
07/04/24 7:00 a.m. 07/04/24 6:13 a.m. SQ Abdomen - LLQ
07/14/24 5:00 p.m. 07/14/24 4:34 p.m. SQ Abdomen - right upper quadrant (RUQ)
07/14/24 9:00 p.m. 07/14/24 9:02 p.m. SQ Abdomen - RUQ
07/23/24 9:00 p.m. 07/23/24 8:14 p.m. SQ Abdomen - LLQ
07/25/24 5:00 p.m. 07/25/24 4:14 p.m. SQ Abdomen - LLQ
08/16/24 9:00 p.m. 08/16/24 8:32 p.m. SQ Abdomen - LUQ
08/17/24 7:00 a.m. 08/17/24 6:42 a.m. SQ Abdomen - LUQ
08/21/24 9:00 p.m. 08/21/24 9:35 p.m. s SQ Abdomen - LUQ
08/22/24 7:00 a.m. 08/22/24 6:22 a.m. SQ Abdomen - LUQ
08/29/24 7:00 a.m. 08/29/24 6:38 a.m. SQ Abdomen - LLQ
08/31/24 7:00 a.m. 08/31/24 7:19 a.m. SQ Abdomen - LLQ
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
056168
If continuation sheet
Page 14 of 48
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
056168
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
10/03/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Granada Hills Convalescent
16123 Chatsworth Ave
Granada Hills, CA 91344
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0658
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
During a concurrent interview and record review on 10/3/2024 at 1:30 p.m., with the Director of Nursing
(DON), reviewed Resident 33's physician's orders, MAR, and location of administration sites for Humalog
injection solution from 8/2024 to 9/2024. The DON verified the insulin injection sites were not rotated. The
DON stated the licensed nurses (LN) should have rotated insulin administration sites to prevent
discoloration, swelling, trauma to the skin. The DON stated the LNs should observe the previous site and
then rotate the site for the next dose of insulin, check the site if it is discolored or bruised and monitor the
resident for pain. The DON stated the LNs should clean and disinfect the area, check the correct dose and
route before administering the medication.
During a review of the facility's policy and procedure (P&P) titled, Insulin Administration, last reviewed on
4/12/2024, the P&P indicated a purpose to provide guidelines for the safe administration of insulin to
residents with diabetes. The P&P indicated:
Select an injection site.
a. Insulin may be injected into the subcutaneous tissue of the upper arm, and the anterior or lateral areas of
the thighs and abdomen. Avoid the area approximately 2 inches around the navel.
b. Injection sites should be rotated, preferably within the same general area (abdomen, thigh, upper arm).
During a review of the facility provided manufacturer's guideline for Humalog injection solution, last revised
on 8/2024, the manufacturer's guideline indicated to change the injection site each time to lessen injury
under the skin such as lumps or thickened skin.
d. During a review of Resident 28's admission Record, the admission Record, the admission Record
indicated the facility admitted the resident on 3/4/2021 and readmitted the resident on 7/28/2024 with
diagnoses including but not limited to type two diabetes mellitus (DM 2 - a disorder characterized by
difficulty on blood sugar control and poor wound healing), long term use of insulin, and lack of coordination.
During a review of Resident 28's History and Physical (H&P) dated 7/29/2024, the H&P indicated the
resident had the capacity to understand and make decisions.
During a review of Resident 28's Minimum Data Set (MDS, a federally mandated resident assessment tool),
dated 8/3/2024, the MDS indicated the resident had moderately impaired cognition (mental action or
process of acquiring knowledge and understanding) and required supervision or touching assistance with
eating, and oral hygiene; partial/moderate assistance from staff with all other activities of daily living (ADLs
- basic tasks that must be accomplished every day for an individual to thrive). The MDS indicated Resident
28 received insulin.
During a review of Resident 28's Order Summary Report, the Order Summary Report indicated the
following physician's order dated 7/28/2024:
Lantus subcutaneous (SQ) solution 100 unit per milliliters (unit/ml - a unit of measurement) [insulin glargine
- a long-acting type of insulin that works slowly over about 24 hours used to lower blood sugar in adults and
children with diabetes] inject 18 units subcutaneously (SQ) one time a day for DM 2.
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
056168
If continuation sheet
Page 15 of 48
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
056168
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
10/03/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Granada Hills Convalescent
16123 Chatsworth Ave
Granada Hills, CA 91344
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0658
During a review of Resident 28's Medication Administration Record (MAR) from 7/2024 to 9/2024, the MAR
indicated Lantus SQ solution was administered as follows:
Level of Harm - Minimal harm
or potential for actual harm
07/16/24 9:00 a.m. 07/16/24 9:04 a.m. SQ Abdomen - right upper quadrant (RUQ)
Residents Affected - Some
07/17/24 9:00 a.m. 07/17/24 9:21 a.m. SQ Abdomen - RUQ
07/20/24 9:00 a.m. 07/20/24 8:20 a.m. SQ Arm - Upper arm (rear) (left)
07/21/24 9:00 a.m. 07/21/24 8:42 a.m. SQ Arm - Upper arm (rear) (left)
08/18/24 9:00 a.m. 08/18/24 8:59 a.m. SQ Arm - Upper arm (rear) (right)
08/23/24 9:00 a.m. 08/23/24 9:40 a.m. SQ Arm - Upper arm (rear) (right)
09/06/24 9:00 a.m. 09/06/24 9:42 a.m. SQ Arm - Upper arm (rear) (left)
09/07/24 9:00 a.m. 09/07/24 8:43 a.m. SQ Arm - Upper arm (rear) (right)
09/27/24 9:00 a.m. 09/27/24 8:51 a.m. SQ Abdomen - left upper quadrant (LUQ)
09/28/24 9:00 a.m. 09/28/24 9:07 a.m. SQ Abdomen - LUQ
09/29/24 9:00 a.m. 09/29/24 8:37 a.m. SQ Arm - Upper arm (rear) (right)
09/30/24 9:00 a.m. 09/30/24 8:45 a.m. SQ Arm - Upper arm (rear) (right)
During a concurrent interview and record review on 10/3/2024 at 1:30 p.m., with the Director of Nursing
(DON), reviewed Resident 28's physician's orders, MAR, and location of administration sites for Lantus SQ
solution from 7/2024 to 9/2024. The DON verified the insulin injection sites were not rotated. The DON
stated the licensed nurses (LN) should have rotated insulin administration sites to prevent discoloration,
swelling, trauma to the skin. The DON stated the LNs should observe the previous site and then rotate the
site for the next dose of insulin, check the site if it is discolored or bruised and monitor the resident for pain.
The DON stated the LNs should clean and disinfect the area, check the correct dose and route before
administering the medication.
During a review of the facility's policy and procedure (P&P) titled, Insulin Administration, last reviewed on
4/12/2024, the P&P indicated a purpose to provide guidelines for the safe administration of insulin to
residents with diabetes. The P&P indicated:
Select an injection site.
a. Insulin may be injected into the subcutaneous tissue of the upper arm, and the anterior or lateral areas of
the thighs and abdomen. Avoid the area approximately 2 inches around the navel.
b. Injection sites should be rotated, preferably within the same general area (abdomen, thigh, upper arm).
During a review of the facility provided manufacturer's guideline for insulin glargine - injection,
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
056168
If continuation sheet
Page 16 of 48
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
056168
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
10/03/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Granada Hills Convalescent
16123 Chatsworth Ave
Granada Hills, CA 91344
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0658
undated, the manufacturer's guideline indicated to change the injection site each time to lessen injury under
the skin such as lumps or thickened skin.
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
056168
If continuation sheet
Page 17 of 48
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
056168
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
10/03/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Granada Hills Convalescent
16123 Chatsworth Ave
Granada Hills, CA 91344
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0689
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
Ensure that a nursing home area is free from accident hazards and provides adequate supervision to
prevent accidents.
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
observation, interview, and record review the facility failed to ensure the resident environment was free of
accident hazards for two of six sampled residents (Residents 15, 44, 31, 6, and 12) investigated under
accidents by failing to ensure
1. Resident 15, 44, 31, and 36's fall mat (a floor mat designed to reduce the risk of injury from fall by
providing a soft-landing surface) did not have medical equipment or furniture on top of the mat.
This deficient practice lessened the effectiveness of the fall mat to prevent falls with injury by placing a
heavy equipment and furniture on top of the fall mat, decreasing its effectiveness to lessen the impact of a
fall due to permanent dented mat surface and placed the residents at risk for injury if they were to hit the
equipment or furniture during a fall.
2. Failing to ensure the portable air conditioning (AC) appliance exhaust panel or sleeve inside Resident
12's window was secured properly and did not fall on top the resident's bed.
This deficient practice had the potential for the panel or sleeve to fall onto the resident while in bed,
resulting in injury.
Findings:
1. a. During a review of Resident 15's admission Record (AR), the AR indicated the facility admitted the
resident on 4/2/2024, with diagnoses including frontotemporal neurocognitive disorder (a group of
conditions that occur when the frontal and temporal lobes of the brain are damaged, causing them to
shrink), age-related osteoporosis (weak and brittle bones due to lack of calcium and Vitamin D), and
long-term use of anticoagulants (a substance that is used to prevent and treat blood clots in blood vessels
and the heart).
During a review of Resident 15's History and Physical (H&P), dated 4/3/2024, the H&P indicated the
resident had the capacity to understand and make decisions.
During a review of Resident 15's Minimum Data Set (MDS, a federally mandated resident assessment tool)
dated 7/7/2024, the MDS indicated the resident had the ability to makes self-understood and understand
others and the resident mostly required substantial to maximal assistance on mobility and activities of daily
living (ADLs, are essential and routine tasks that most young, healthy individuals can perform without
assistance).
During a review of Resident 15's Order Summary Report, dated 4/3/2024, the report indicated an order for
low bed with left sided floor mat every shift.
During a review of Resident 15's Fall Risk Assessment (FRA), dated 4/3/2024, the FRA indicated the
resident was high risk for falls.
During an observation on 10/1/2024, at 9:18 a.m., observed Resident 15's fall mat placed on the right side
of the bed, with a side table and an oxygen concentrator (a medical device that removes
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
056168
If continuation sheet
Page 18 of 48
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
056168
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
10/03/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Granada Hills Convalescent
16123 Chatsworth Ave
Granada Hills, CA 91344
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0689
nitrogen from the air and produces oxygen for breathing) resting on top of the mat.
Level of Harm - Minimal harm
or potential for actual harm
During a concurrent observation and interview on 10/3/2024, at 9:17 a.m., with Certified Nursing Assistant
1 (CNA 1), inside Resident 15's room, observed the resident's fall mat 15's fall mat placed on the right side
of the bed, with a side table and an oxygen concentrator resting on top of the mat. CNA 1 stated the side
table should not be on top of the fall mat to prevent injury if the resident falls.
Residents Affected - Some
During an interview on 10/3/2024, at 1:06 p.m., with the Director of Nursing (DON), the DON stated there
should be no equipment or furniture on top of the fall mat to prevent damaging the fall mat, creating a
permanent dent, and defeating the purpose of lessening the impact of a fall. The DON stated placing
equipment or furniture on top of the mat increases the resident's risk of injury if the resident hits the
equipment or furniture in the event of a fall.
During a review of the facility's recent policy and procedure (P&P) titled, Floor Mat Application, last
reviewed on 4/12/2024, the P&P indicated to apply the ordered floor mat using the appropriate procedure.
Follow the instructions provided by the manufacturer.
During a review of the facility provided Manufacturer's Guideline on the use of Beveled Floor Mat 1 (BFM
1), undated, the guideline indicated to never leave heavy materials on the mat for an extended amount of
time and may cause a permanent indentation.
1.b. During a Review of Resident 144's admission Record (AR), the AR indicated the facility admitted the
resident on 9/25/2024, with diagnoses including lack of coordination, muscle weakness, and dementia (a
chronic condition that causes a decline in cognitive functioning, such as thinking, remembering, and
reasoning, to the point that it interferes with daily life).
During a review of Resident 144's H&P, dated 9/27/2024, the H&P indicated the resident was old, frail,
confused, and agitated. The H&P indicated the resident does not have the capacity to make decisions.
During a review of Resident 144's MDS, dated [DATE], the MDS indicated the resident usually make
self-understood and understand others and the resident was mostly dependent on mobility and activities of
daily living (ADLs).
During a review of Resident 144's Order Summary Report, dated 9/30/2024, the report indicated an order
for low bed with left sided floor mat every shift.
During a review of Resident 144's Side Rail Assessment (SRA), dated 9/26/2024, the SRA indicated the
resident had medical symptoms of weakness, balance deficit, and had intermittent confusion/forgetfulness.
During a review of Resident 144's Care Plan (CP) titled Psychotropic drug (a drug or other substance that
affects how the brain works and causes changes in mood, awareness, thoughts, feelings, or behavior) use,
last revised on 9/30/2024, the CP indicated an intervention to provide a safe and hazard-free environment.
During an observation on 10/1/2024, at 9:43 a.m., observed Resident 144 lying in bed with bilateral
(relating to two sides) floor mats. The side table was resting on the left mat, and the oxygen
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
056168
If continuation sheet
Page 19 of 48
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
056168
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
10/03/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Granada Hills Convalescent
16123 Chatsworth Ave
Granada Hills, CA 91344
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0689
concentrator on the right mat.
Level of Harm - Minimal harm
or potential for actual harm
During a concurrent observation and interview on 10/3/2024, at 9:27 a.m., with CNA 1, inside Resident
144's room, observed Resident 144 lying in bed with bilateral (relating to two sides) floor mats. The side
table was resting on the left mat, and the oxygen concentrator on the right mat. CNA 1 stated there should
be no equipment or furniture on top of the fall mat to prevent injury if the resident falls.
Residents Affected - Some
During an interview on 10/3/2024, at 1:06 p.m., with the Director of Nursing (DON), the DON stated there
should be no equipment or furniture on top of the fall mat to prevent damaging the fall mat, creating a
permanent dent, and defeating the purpose of lessening the impact of a fall. The DON stated placing
equipment or furniture on top of the mat increases the resident's risk of injury if the resident hits the
equipment or furniture in the event of a fall.
During a review of the facility's recent policy and procedure (P&P) titled, Floor Mat Application, last
reviewed on 4/12/2024, the P&P indicated to apply the ordered floor mat using the appropriate procedure.
Follow the instructions provided by the manufacturer.
During a review of the facility provided Manufacturer's Guideline on the use of BFM 1, undated, the
guideline indicated to never leave heavy materials on the mat for an extended amount of time and may
cause a permanent indentation.
c. During a review of Resident 31's admission Record, the admission Record indicated the facility admitted
the resident on 8/9/2024 with diagnoses including but not limited to dementia (a progressive state of decline
in mental abilities), depression (a mood disorder that causes a persistent feeling of sadness and loss of
interest), and mild protein-calorie nutrition (a type of undernutrition when a person does not consume
enough protein and calories which may lead to muscle loss, fat loss, and the body not working as it usually
would).
During a review of Resident 31's History and Physical (H&P) dated 8/10/2024, the H&P indicated the
resident did not have the capacity to understand and make decisions.
During a review of Resident 31's MDS dated [DATE], the MDS indicated the resident had severely impaired
cognition (mental action or process of acquiring knowledge and understanding) and required
partial/moderate assistance with eating, and oral hygiene, and substantial/maximal with all other activities
of daily living (ADLs - basic tasks that must be accomplished every day for an individual to thrive). The MDS
indicated Resident 31 had impairment on both lower extremities.
During a review of Resident 31's care plan (CP), the CP on risk for falls related to but not limited to balance
problem with standing, balance problem with walking, joint pains, mental status initiated 8/14/2024 with
target date 11/10/2024 indicated an intervention for low bed with right mat to prevent or minimize falls.
During a review of Resident 31's Order Summary Report, the Order Summary Report indicated a
physician's order dated 8/9/2024 for low bed with right floor mat.
During a concurrent observation and interview on 10/1/2024 at 9:37 a.m., inside Resident 31's room with
the Director of Nursing (DON), the DON verified Resident 31's wheelchair and overbed table were placed
on top of the floor mat. The DON verified an indentation was evident when the wheelchair was
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
056168
If continuation sheet
Page 20 of 48
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
056168
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
10/03/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Granada Hills Convalescent
16123 Chatsworth Ave
Granada Hills, CA 91344
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0689
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
removed on top of the floor mat. The DON stated leaving heavy equipment for an extended period of time
on top of the floor may affect the integrity of the floor mat.
During an interview on 10/3/2024, at 1:06 p.m., with the Director of Nursing (DON), the DON stated there
should be no equipment or furniture on top of the fall mat to prevent damaging the fall mat, creating a
permanent dent, and defeating the purpose of lessening the impact of a fall. The DON stated placing
equipment or furniture on top of the mat increases the resident's risk of injury if the resident hits the
equipment or furniture in the event of a fall.
During a review of the facility's policy and procedure (P&P) titled, Accidents & Hazards, last reviewed
4/12/2024, indicated:
All hazardous areas, devices, and equipment in the facility will be identified and addressed appropriately to
ensure resident safety and mitigate accident hazards to the extent possible.
As part of the facility's overall safety and accident prevention program, hazardous areas and objects in the
resident environment will be identified and addressed by the safety committee.
A hazard is defined as anything in the environment that has the potential to cause injury or illness.
Examples of environmental hazards include, but are not limited to the following:
f. Objects in the hallways that obstruct a clear path.
j. Furniture that is unstable or positioned at an improper height for residents.
During a review of the facility's policy and procedure(P&P) titled, Floor Mat Application, last reviewed on
4/12/2024, the P&P indicated to apply the ordered floor mat using the appropriate procedure. Follow the
instructions provided by the manufacturer.
During a review of the facility provided manufacturer's guideline for Bed Floor Mat 1 (BFM 1), undated, the
manufacturer's guideline indicated to never leave heavy materials on the mat for an extended amount of
time and they may cause permanent indentation.
D. During a review of Resident 6's admission Record, the admission Record indicated the facility admitted
the resident on 11/29/2011 and readmitted in the facility on 6/7/2022 with diagnoses including but not
limited to dementia, blindness left eye, and schizophrenia (a mental disorder characterized by delusions [a
fixed false belief that conflicts with reality], hallucinations [sensory experiences that only exist in the mind],
disorganized thoughts, speech and behavior).
During a review of Resident 6's History and Physical (H&P) dated 5/13/2024, the H&P indicated the
resident had fluctuating capacity to understand and make decisions.
During a review of Resident 6's Minimum Data Set, dated [DATE], the MDS indicated the resident had
severely impaired cognition (mental action or process of acquiring knowledge and understanding) and
required supervision/touching assistance with eating; partial/moderate assistance with oral hygiene and
toileting hygiene, roll left to right, sit to lying, and lying to sitting onside of bed; substantial/maximal with all
other activities of daily living (ADLs - basic tasks that must be accomplished every day for an individual to
thrive). The MDS indicated Resident 6 had impairment on both lower extremities.
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
056168
If continuation sheet
Page 21 of 48
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
056168
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
10/03/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Granada Hills Convalescent
16123 Chatsworth Ave
Granada Hills, CA 91344
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0689
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
During a review of Resident 6's care plan (CP), the CP on risk for falls related to but not limited to balance
problem with standing, balance problem with walking, psychiatrics medication use initiated 6/9/2022 last
revised 9/7/2023, indicated floor mat as one of the interventions to minimize falls.
During a review of Resident 6's Order Summary Report, the Order Summary Report indicated a physician's
order dated 8/17/2022, indicated to monitor for placement of low bed with right floor mat.
During a concurrent observation and interview on 10/1/2024 at 9:46 a.m. inside Resident 6's room with
Licensed Vocational Nurse 2 (LVN 2), observed resident lying in bed, with the wheelchair and overbed table
resting on top of the right floor mat. LVN 2 stated leaving the wheelchair and overbed table on top of the
floor mat could create dents, reducing the mat's effectiveness in preventing injury during a fall.
During an interview on 10/3/2024, at 1:06 p.m., with the Director of Nursing (DON), the DON stated there
should be no equipment or furniture on top of the fall mat to prevent damaging the fall mat, creating a
permanent dent, and defeating the purpose of lessening the impact of a fall. The DON stated placing
equipment or furniture on top of the mat increases the resident's risk of injury if the resident hits the
equipment or furniture in the event of a fall.
During a review of the facility's policy and procedure (P&P) titled, Accidents & Hazards, last reviewed
4/12/2024, indicated:
All hazardous areas, devices, and equipment in the facility will be identified and addressed appropriately to
ensure resident safety and mitigate accident hazards to the extent possible.
As part of the facility's overall safety and accident prevention program, hazardous areas and objects in the
resident environment will be identified and addressed by the safety committee.
A hazard is defined as anything in the environment that has the potential to cause injury or illness.
Examples of environmental hazards include, but are not limited to the following:
f. Objects in the hallways that obstruct a clear path.
j. Furniture that is unstable or positioned at an improper height for residents.
2. During a review of Resident 12's admission Record, the admission Record indicated the facility admitted
the resident on 8/30/2024 with diagnoses including but not limited to history of falling, right knee
osteoarthritis (inflammation of one or more joints; a condition that occurs when the joints gradually
deteriorates).
During a review of Resident 12's History and Physical (H&P) dated 9/3/2024, the H&P indicated the
resident had the capacity to understand and make decisions.
During a review of Resident 12's Minimum Data Set (MDS, a federally mandated resident assessment tool),
dated 9/12/2024, the MDS indicated the resident had moderately impaired cognition (mental action or
process of acquiring knowledge and understanding) and required partial/moderate assistance with eating
and oral hygiene; dependent on staff with sit to stand and transfers; substantial/maximal with all other
activities of daily living (ADLs - basic tasks that must be accomplished every day for
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
056168
If continuation sheet
Page 22 of 48
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
056168
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
10/03/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Granada Hills Convalescent
16123 Chatsworth Ave
Granada Hills, CA 91344
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0689
an individual to thrive). The MDS indicated Resident 12 had impairment on the right lower extremity.
Level of Harm - Minimal harm
or potential for actual harm
During a concurrent observation and interview on 10/1/2024 at 10:26 a.m., inside Resident 12's room,
observed the resident in the wheelchair using an electronic tablet device. Observed the right side of the bed
placed against the wall, with a portable air conditioning unit duct (tubes or pipes that carry air in and out of
the building) going through the window to the exterior of the building. When checked, the panel or sleeve
covering the opening on the window dropped on top of Resident 12's bed at the foot part . Resident 12
stated she did not know why there is a portable AC was in the room when she did not have any issues with
temperature.
Residents Affected - Some
During an interview on 10/1/2024 at 10:40 a.m., the Maintenance Supervisor (MS) stated the piece of panel
or sleeve that fell on top of Resident 12's bed was a hard piece of plastic.
During a follow up interview on 10/2/2024 at 3:45 p.m., the MS stated the piece of panel or sleeve was part
of the installation kit for the portable AC that should have been secured properly to prevent from falling onto
the resident and causing injury.
During an interview on 10/3/2024 at 1:39 p.m., with the Director of Nursing (DON), the DON stated the
panel for the portable AC exhaust should have been secured properly on the window to prevent from falling
onto the resident and causing injury.
During a review of the facility's policy and procedure (P&P) titled, Policy for Portable HVAC Usage, last
reviewed 4/12/2024, the P&P indicated a purpose to provide guidelines for the safe and effective use of
portable HVAC units within the skilled nursing facility, ensuring a comfortable environment for the residents
while maintaining compliance with health and safety regulations.
During a review of the facility's policy and procedure (P&P) titled, Accidents & Hazards, last reviewed
4/12/2024, indicated:
All hazardous areas, devices, and equipment in the facility will be identified and addressed appropriately to
ensure resident safety and mitigate accident hazards to the extent possible.
As part of the facility's overall safety and accident prevention program, hazardous areas and objects in the
resident environment will be identified and addressed by the safety committee.
A hazard is defined as anything in the environment that has the potential to cause injury or illness.
Examples of environmental hazards include, but are not limited to the following:
f. Objects in the hallways that obstruct a clear path.
j. Furniture that is unstable or positioned at an improper height for residents.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
056168
If continuation sheet
Page 23 of 48
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
056168
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
10/03/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Granada Hills Convalescent
16123 Chatsworth Ave
Granada Hills, CA 91344
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0693
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Ensure that feeding tubes are not used unless there is a medical reason and the resident agrees; and
provide appropriate care for a resident with a feeding tube.
Based on observation, interview, and record review, the facility failed to ensure residents receiving enteral
feeding (also known as tube feeding, a method of supplying nutrients directly into the gastrointestinal [the
body's system for processing liquids and foods] tract) received appropriate care and services to prevent
complications of enteral feeding for one out of two sampled residents (Resident 27) by failing to ensure the
enteral feeding tube tip attached to a Y adapter (a three-way connector in which two ends are adjacent to
the tubing) was covered with a cap when not in use.
The deficient practice had the potential to contaminate the enteral feeding system.
Findings:
During a review of Resident 27's admission Record (AR), the AR indicated the facility admitted the resident
on 1/6/2021, and readmitted the resident on 11/25/2022, with diagnoses including gastro-esophageal reflux
disease (GERD, is a chronic digestive disorder that occurs when stomach contents flow back into the
esophagus) and dysphagia (difficulty swallowing).
During a review of Resident 27's History and Physical (H&P), dated 8/2/2023, the H&P indicated the
resident does not have the capacity to understand and make decisions.
During a review of Resident 27's Minimum Data Set (MDS, a federally mandated resident assessment tool),
dated 9/3/2024, the MDS indicated the resident rarely to never had the ability to make self-understood and
understand others. The MDS indicated the resident had a feeding tube.
During a review of Resident 27's Order Summary Report, the report indicated an order for:
11/25/2022 Change Y adapter every (q) 2 weeks by night (NOC) shift (11p-7a) every night shift every 14
days.
1/23/2024 Continuous gastrostomy tube feeding formula Jevity 1.5 at 84 cubic centimeter per hour (cc/hr., a
measure of volume flow rate) times (X) 20 hrs. to provide 1680 milliliters (ml, a unit of volume)/2016 calories
(Cal, a unit of energy)/24 hrs. Start infusion pump (a medical device that delivers fluids, such as nutrients
and medications) at 2 p.m. until 10 p.m. or until dose met. Two times a day.
During a concurrent observation and interview on 10/1/2024, with Licensed Vocational Nurse 2 (LVN 2),
inside Resident 27's room, observed Resident 27's feeding off and disconnected from the resident. The Y
adapter tubing that was attached to the feeding system was not capped. LVN 2 stated the Y adapter tubing
should be capped or placed in a clean plastic bag when not in use for infection control.
During an interview on 10/3/2024, at 1:26 p.m., with the Director of Nursing (DON), the DON stated
Resident 27's Y adapter should be capped when not in use to prevent gastrointestinal infection.
During a review of the facility's recent policy and procedure (P&P) titled, Enteral Feedings- Safety
Precautions, last reviewed on 4/12/2024, the P&P indicated to ensure the safe administration of enteral
nutrition. Ensure tubing are capped when not in use.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
056168
If continuation sheet
Page 24 of 48
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
056168
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
10/03/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Granada Hills Convalescent
16123 Chatsworth Ave
Granada Hills, CA 91344
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0695
Provide safe and appropriate respiratory care for a resident when needed.
Level of Harm - Minimal harm
or potential for actual harm
Based on observation, interview, and record review the facility failed to ensure residents who need
respiratory care are provided care consistent with professional standards of practice for one of two sampled
residents (Resident 32) investigated under respiratory care by failing to ensure:
Residents Affected - Few
1. A physician's order was obtained for Resident 32's use of bilevel positive airway pressure (BIPAP, a
noninvasive machine that helps people breathe).
2. The BIPAP mask and tubing were kept off the floor.
These deficient practices had a potential for Resident 32 to develop respiratory complications.
Findings:
During a review of Resident 32's admission Record (AR), the AR indicated the facility admitted the resident
on 7/25/2022, and readmitted the resident on 9/22/2024, with diagnoses including acute respiratory failure
with hypercapnia (a condition where the lungs have trouble removing carbon dioxide from the blood,
causing a buildup of carbon dioxide in the blood), pleural effusion (a condition where too much fluid builds
up in the space between the lungs and chest wall), and dependence on supplemental oxygen (a medical
treatment that provides extra oxygen to people who have trouble breathing or low blood oxygen levels).
During a review of Resident 32's History and Physical (H&P), dated 9/23/2024, the H&P indicated the
resident had acute hypoxemic respiratory failure (occurs when there is not enough oxygen in the blood) and
to continue with budesonide (a steroid medication used to treat inflammatory diseases, such as asthma
and rhinitis, and to reduce swelling in the lungs) and DuoNeb (combines ipratropium and albuterol to treat
chronic obstructive pulmonary disease). The H&P indicated the resident had the capacity to make
decisions.
During a review of Resident 32's Minimum Data Set (MDS, a federally mandated resident assessment tool),
dated 9/26/2024, the MDS indicated the resident had the ability to make self-understood and understand
others. The MDS indicated the resident was on continuous oxygen therapy (a treatment that involves
supplying oxygen at a higher concentration than room air to treat and prevent hypoxemia).
During a review of Resident 32's Order Summary Report, the report did not indicate an order for a BIPAP
machine.
During a review of Resident 32's Care Plan titled Respiratory risk related to COPD, acute hypoxemic
hypercapnia respiratory failure, last revised on 9/27/2024, the CP indicated an intervention of appropriate
equipment at bedside for emergency use, breathing treatment as ordered, and medication as ordered:
Budesonide, DuoNeb.
During a concurrent observation, interview, and record review, on 10/1/2024, at 3:35 p.m., inside Resident
32's room, with the Infection Preventionist (IP), observed a BIPAP machine on the resident's side table's
drawer with the BIPAP's tubing and mask on the floor. The IP stated the BIPAP tubing mask should be off
the floor to prevent respiratory infection to the resident. During a review of the resident's Order Summary
Report, the IP stated there is no order for the resident to use a BIPAP. The IP stated it is important to have a
physician's order for the use of BIPAP to ensure the machine
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
056168
If continuation sheet
Page 25 of 48
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
056168
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
10/03/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Granada Hills Convalescent
16123 Chatsworth Ave
Granada Hills, CA 91344
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0695
has the correct settings to provide the appropriate therapy to the resident.
Level of Harm - Minimal harm
or potential for actual harm
During an interview on 10/3/2024, at 1:20 p.m., with the Director of Nursing (DON), the DON stated there
should be an order on the use of BIPAP for resident safety and to prevent respiratory distress to the
resident.
Residents Affected - Few
During a review of the facility's recent policy and procedure (P&P) titled, Physician Orders, last reviewed on
4/12/2024, the P&P indicated orders for medications and treatments will be consistent with principles of
safe and effective order writing.
During a review of the facility's recent policy and procedure (P&P) titled, Policy and Procedure for
BIPAP/CPAP Machine Usage, last reviewed on 4/12/2024, the P&P indicated a physician or qualified
healthcare provider must evaluate the resident and confirm the need for BIPAP/CPAP therapy.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
056168
If continuation sheet
Page 26 of 48
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
056168
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
10/03/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Granada Hills Convalescent
16123 Chatsworth Ave
Granada Hills, CA 91344
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0755
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Provide pharmaceutical services to meet the needs of each resident and employ or obtain the services of a
licensed pharmacist.
Based on observation, interview, and record review the facility failed to accurately and safely provide or
obtain pharmaceutical services to one (1) of three (3) sampled residents (Resident 36) investigated during
medication administration task. The facility failed to flush the medications in between administration via
gastrostomy tube (G-tube - a medical device that is inserted through the abdomen into the stomach to
provide nutrition, fluids, and medications to patients who are unable to consume food or liquids by mouth).
This deficient practice had the potential to place Resident 36 at risk of health complications such as drug
interaction and delay in the provision of care.
Findings:
During a review of Resident 36's admission Record, the admission Record indicated the facility admitted
the resident on 3/9/2024 and was readmitted into the facility on 4/17/2024 with diagnoses that included
dementia (a general term for a condition with loss of memory, language, problem-solving and other thinking
abilities that are severe enough to interfere with daily life), gastrostomy status, and chronic pain syndrome.
During a review of Resident 36's History and Physical (H&P) dated 12/17/2023, the H&P indicated the
resident could make needs known but was unable to make medical decisions.During a review of Resident
36's Minimum Data Set (MDS, a standardized assessment and care screening tool), dated 7/23/2024, the
MDS indicated the resident had severely impaired cognition (mental action or process of acquiring
knowledge and understanding) and was totally dependent on staff with all activities of daily living (ADLs basic tasks that must be accomplished every day for an individual to thrive). The MDS indicated Resident
36 had impairment of both upper and both lower extremities and received feeding thru the tube.
During a review of Resident 36's Order Summary Report, the Order Summary Report indicated the
following physician orders:
4/17/2024: May crush all crushable medications given via G-tube every shift.
4/17/2024: Flush gastrostomy tube with 30 milliliters (ml - a unit of measurement) of water pre (before) and
post (after) medication administration.
4/17/2024: Check G-tube residual every shift if 150 ml or greater, stop feeding and notify physician.
4/17/2024: Check G-tube placement every shift.
6/27/2024: Continuous G-tube feeding formula: Glucerna (a type of feeding formula that is calorically dense
designed for patients with diabetes or elevated glucose response) 1.5 at 60 ml per hour (ml/hr - a unit of
measurement) for 20 hours to provide 1200 ml per 1800 calories for 24 hours. Start infusion pump at 4:00
p.m. until 10 :00 a.m. or until dose met.
During a review of Resident 36's care plan on nutritional problem related to enteral feeding (- a
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
056168
If continuation sheet
Page 27 of 48
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
056168
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
10/03/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Granada Hills Convalescent
16123 Chatsworth Ave
Granada Hills, CA 91344
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0755
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
form of nutrition that is delivered into the digestive system as a liquid) initiated 4/25/2024 last revised
6/27/2024 indicated to administer medications as ordered and to monitor/document for side effects and
effectiveness.During a medication administration observation on 10/2/2024 at 8:58 a.m. inside Resident
36's room with Licensed Vocational Nurse 2 (LVN 2), LVN 2 was observed checking the resident's G-tube
placement and residual prior to administration of medications. LVN 2 administered the first medication
mixed with 10 ml of water, clamped the tube and was about to administer the second medication without
flushing with water prior administration. When asked, LVN 2 stated she should have flushed the G-tube with
at least 10 ml of water in between each medication to ensure the medication was fully administered and
there was no clog, and to ensure there was no drug interaction in between medications.
During an interview on 10/3/2024 at 2:29 p.m. the Director of Nursing (DON) stated during medication
administration via G-tube, the nurses should flush the G-tube with at least 10 ml of water in between each
medication to ensure all the medications were all absorbed fully and to ensure there was no drug
interaction in between the medications.
A facility's policy and procedure (P&P) titled, Administering Medications through an Enteral Tube, last
reviewed 4/12/2024, indicated a purpose to provide guidelines for the safe administration of medications
through an enteral tube. The P&P indicated:
Administer each medication separately.
If administering more than one medication, flush with 10 ml water (or prescribed amount) between
medications.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
056168
If continuation sheet
Page 28 of 48
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
056168
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
10/03/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Granada Hills Convalescent
16123 Chatsworth Ave
Granada Hills, CA 91344
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0757
Ensure each resident’s drug regimen must be free from unnecessary drugs.
Level of Harm - Minimal harm
or potential for actual harm
Based on interview and record review the facility failed to ensure the resident's drug regimen was free from
unnecessary drugs for one of two sampled residents (Resident 27) investigated under anticoagulants (a
substance that is used to prevent and treat blood clots in blood vessels and the heart) by failing to ensure
there was adequate monitoring on the use of an anticoagulant-Apixaban.
Residents Affected - Few
The deficient practice had the potential to predispose the resident on the adverse effect (a harmful or
abnormal result) of anticoagulant use such as bleeding.
Findings:
During a review of Resident 27's admission Record (AR), the AR indicated the facility admitted the resident
on 1/6/2021, and readmitted the resident on 11/25/2022, with diagnoses including atrial fibrillation (a heart
condition that causes an irregular heartbeat, often faster than normal), gastro-esophageal reflux disease
(GERD, a chronic digestive disorder that occurs when stomach contents flow back into the esophagus),
and long-term use of anticoagulants.
During a review of Resident 27's History and Physical (H&P), dated 8/2/2023, the H&P indicated the
resident did not have the capacity to understand and make decisions.
During a review of Resident 27's Minimum Data Set (MDS, a federally mandated resident assessment tool),
dated 9/3/2024, the MDS indicated the resident rarely to never had the ability to make self-understood and
understand others. The MDS indicated the resident was on a high-risk drug class anticoagulant.
During a review of Resident 27's Order Summary Report, dated 11/25/2022, the report indicated an order
for Apixaban Tablet 2.5 milligrams (mg., a unit of weight) Give 1 tablet via gastrostomy tube (G-Tube, a
small flexible tube that is surgically inserted through the abdomen and into the stomach to provide nutrition,
fluids, and medicine) two times a day for cerebrovascular accident (CVA, a medical condition that occurs
when blood flow to the brain is suddenly interrupted) prophylaxis (PPX, an attempt to prevent disease).
During a review of Resident 27's Care Plan (CP) titled The resident is at risk for easy bruising and/or
bruising due to fragile skin, intake of ASA/Anticoagulants: Apixaban, last revised on 9/3/2024, the CP
indicated an intervention to monitor for discolored urine, black tarry stools, sudden severe headache,
nausea and vomiting (N&V), diarrhea, muscle joint pain, lethargy, bruising, sudden changes in mental
status and/or vital signs, shortness of breath (SOB), nose bleeds and tally by hashmarks.
During a concurrent interview and record review on 10/3/2024, at 1:03 p.m., with the Director of Nursing
(DON), the Order Summary Report and the Medication Administration Record (MAR) for Resident 27 was
reviewed. The DON stated there was an order for Apixaban 2.5 mg tablet via G-Tube twice a day, however,
there was no order for monitoring for adverse effects on the use of anticoagulant- Apixaban. The DON
opened the MARs and found no monitoring done for the use of the Apixaban since it was ordered. The
DON checked the CP and found an intervention on the plan to monitor for discolored urine, black tarry
stools, sudden severe headache, N&V, diarrhea, muscle joint pain, lethargy, bruising, sudden changes in
mental status and/or vital signs, SOB, nose bleeds and tally by hashmarks but it was not done because it
was not populated in the MAR. The DON stated it is important to assess for
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
056168
If continuation sheet
Page 29 of 48
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
056168
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
10/03/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Granada Hills Convalescent
16123 Chatsworth Ave
Granada Hills, CA 91344
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0757
adverse effects of the anticoagulant such as bleeding to report to the physician and intervene timely.
Level of Harm - Minimal harm
or potential for actual harm
During a review of the facility's recent policy and procedure (P&P) titled, Anticoagulation- Clinical Protocol,
last reviewed on 4/12/2024, the P&P indicated assess for any signs or symptoms related to adverse drug
reactions due to the medication alone or in combination with other medications.
Residents Affected - Few
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
056168
If continuation sheet
Page 30 of 48
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
056168
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
10/03/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Granada Hills Convalescent
16123 Chatsworth Ave
Granada Hills, CA 91344
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0760
Ensure that residents are free from significant medication errors.
Level of Harm - Minimal harm
or potential for actual harm
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
interview and record review the facility failed to ensure residents were free of any significant medication
errors (means the observed or identified preparation or administration of medications or biologicals which is
not in accordance with the prescriber's order, manufacturer's specifications, and accepted professional
standards) for four of four sampled residents (Residents 11, 144, 33, and 28) investigated during review of
insulin (a hormone that lowers the level of glucose [a type of sugar] in the blood) care area by failing to
ensure licensed nurses rotate (a method to ensure repeated injections are not administered in the same
area) subcutaneous (beneath the skin) insulin administration sites.
Residents Affected - Some
The deficient practices had the potential for adverse effect (unwanted, unintended result) of same site
subcutaneous administration of insulin such as lipodystrophy (abnormal distribution of fat) and cutaneous
amyloidosis (is a condition in which clumps of abnormal proteins called amyloids build up in the skin).
Cross Reference F658
Findings:
a. During a review of Resident 11's admission Record (AR), the AR indicated the facility admitted the
resident on 8/12/2024, with diagnoses including type 2 diabetes mellitus (DM2, a chronic disease
characterized by difficulty in blood sugar control and poor wound healing), dysphagia (difficulty swallowing),
and long-term use of insulin.
During a review of Resident 11's History and Physical (H&P), the H&P indicated the resident had the ability
to make his needs known but cannot make medical decisions.
During a review of Resident 11's Minimum Data Set (MDS, a federally mandated resident assessment tool),
the MDS indicated the resident had the ability to make self-understood and understand others. The MDS
indicated the resident receiving hypoglycemic (a class of drugs that help lower blood sugar levels)
medications.
During a review of Resident 11's Order Summary Report, dated 8/12/2024, the report indicated an order for
Humalog Injection Solution 100 units per milliliters (unit/ml, a milliliter is a unit of fluid volume equal to
one-thousandth of a liter) (Insulin Lispro). Inject as per sliding scale (progressive increase in premeal or
nighttime insulin doses): if 150-200= 2 units (the standard amount required for a precise measured activity);
201-250= 4 units; 251-300= 6 units; 301-350= 8 units; 351-400= 10 units call MD if blood sugar (BS)
greater than (>) 400 or less than (<) 60, subcutaneously before meals and at bedtime for DM2.
During a review of Resident 11's Location of Administration Report for Insulin for 8/2024 to 10/2024, the
report indicated Humalog injection solution 100 unit/ml was administered on the following dates and sites:
8/13/2024 at 8:20 p.m. on the Abdomen - Right Upper Quadrant (RUQ)
8/14/2024 at 11:18 a.m. on the Abdomen - RUQ
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
056168
If continuation sheet
Page 31 of 48
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
056168
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
10/03/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Granada Hills Convalescent
16123 Chatsworth Ave
Granada Hills, CA 91344
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0760
8/15/2024 at 11:21 a.m. on the Abdomen - Right Lower Quadrant (RLQ)
Level of Harm - Minimal harm
or potential for actual harm
8/15/2024 at 9:09 p.m. on the Abdomen - RLQ
8/16/2024 at 11:31 a.m. on the Abdomen - RUQ
Residents Affected - Some
8/17/2024 at 12:35 p.m. on the Abdomen - RUQ
8/18/2024 at 5:52 p.m. on the Abdomen - RLQ
8/18/2024 at 8:33 p.m. on the Abdomen - RLQ
8/19/2024 at 4:34 p.m. on the Abdomen - RLQ
8/21/2024 at 12:28 p.m. on the Abdomen - RLQ
8/22/2024 at 11:30 a.m. on the Abdomen - RLQ
8/23/2024 at 10 p.m. on the Abdomen - RLQ
8/25/2024 at 8:15 p.m. on the Abdomen - RLQ
9/10/2024 at 8:12 p.m. on the Abdomen-RLQ
9/16/2024 at 9:28 p.m. on the Abdomen-RLQ
9/29/2024 at 12:41 p.m. on the Abdomen-RLQ
9/29/2024 at 8:22 p.m. on the Abdomen-RLQ
During a concurrent interview and record review on 10/3/2024, at 12:54 p.m., with the Director of Nursing
(DON), reviewed Resident 11's Order Summary Report and Location of Administration Record of insulin
dated 8/2024 to 10/2024. The DON stated there were multiple instances when the licensed nurses did not
rotate the resident's insulin administration sites. The DON stated the licensed nurses should have rotated
the insulin administration sites to prevent discoloration, swelling, and trauma to the skin frequently
administered with insulin. The DON stated not rotating insulin administration sites is a medication error.
During a review of the facility's recent policy and procedure (P&P) titled Adverse Consequences and
Medication Errors, last reviewed on 4/12/2024, the P&P indicated a medication error is defined as the
preparation or administration of drugs or biological which is not in accordance with physician's orders,
manufacturer specifications, or accepted professional standards and principles of the professional(s)
providing services.
During a review of the facility's recent policy and procedure (P&P) titled, Insulin Administration, last
reviewed on 4/12/2024, the P&P indicated to provide guidelines for the safe administration of insulin to
residents with diabetes. Select an injection site.
a. Insulin may be injected into the subcutaneous tissue of the upper arm, and the anterior or
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
056168
If continuation sheet
Page 32 of 48
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
056168
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
10/03/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Granada Hills Convalescent
16123 Chatsworth Ave
Granada Hills, CA 91344
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0760
lateral areas of the thighs and abdomen. Avoid the area approximately 2 inches around the navel.
Level of Harm - Minimal harm
or potential for actual harm
b. Injection sites should be rotated, preferably within the same general area (abdomen, thigh, upper arm).
Residents Affected - Some
During a review of the facility provided Manufacturer's Guideline on the use of Lispro- Injection, last revised
on 8/2024, the guideline indicated to change the injection site each time to lessen injury under the skin (for
example, pits/lumps or thickened skin).
b. During a review of Resident 144's admission Record (AR), the AR indicated the facility admitted the
resident on 9/25/2024, with diagnoses including type 2 diabetes mellitus, chronic kidney disease (a
long-term condition where the kidneys are damaged and cannot filter blood properly), and long-term use of
insulin.
During a review of Resident 144's H&P, dated 9/27/2024, the H&P indicated the resident did not have the
capacity to make decisions.
During a review of Resident 144's MDS, dated [DATE], the MDS indicated the resident sometimes had the
ability to make self-understood and understand others. The MDS indicated the resident was receiving
hypoglycemic medications.
During a review of Resident 144's Order Summary Report, dated 9/25/2024, the report indicated an order
for Insulin Lispro Injection Solution 100 unit/ml (Insulin Lispro). Inject as per sliding scale: if 151-200= 2
units contact MD for blood sugar less than 70; 201-249= 4 units; 250-300= 6 units; contact MD for blood
sugar above 400, subcutaneously two times a day for DM.
During a review of Resident 144's Location of Administration Report for insulin for 9/2024 to 10/2024, the
report indicated Insulin Lispro Injection Solution 100 unit/ml was administered on the following dates and
sites:
9/29/2024 at 8:22 p.m. on the Abdomen - Left Lower Quadrant (LLQ)
9/30/2024 at 9:24 p.m. on the Abdomen - LLQ
During a concurrent interview and record review on 10/3/2024, at 12:54 p.m., with the DON, reviewed
Resident 144's Order Summary Report and Location of Administration Record of insulin dated 9/2024 to
10/2024. The DON stated there were instances when the licensed nurses did not rotate the resident's
insulin administration sites. The DON stated the licensed nurses should have rotated the insulin
administration sites to prevent discoloration, swelling, and trauma to the skin frequently administered with
insulin. The DON stated not rotating insulin administration sites is a medication error.
During a review of the facility's recent policy and procedure (P&P) titled Adverse Consequences and
Medication Errors, last reviewed on 4/12/2024, the P&P indicated a medication error is defined as the
preparation or administration of drugs or biological which is not in accordance with physician's orders,
manufacturer specifications, or accepted professional standards and principles of the professional(s)
providing services.
During a review of the facility's recent policy and procedure (P&P) titled, Insulin Administration, last
reviewed on 4/12/2024, the P&P indicated to provide guidelines for the safe administration of
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
056168
If continuation sheet
Page 33 of 48
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
056168
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
10/03/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Granada Hills Convalescent
16123 Chatsworth Ave
Granada Hills, CA 91344
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0760
insulin to residents with diabetes. Select an injection site.
Level of Harm - Minimal harm
or potential for actual harm
a. Insulin may be injected into the subcutaneous tissue of the upper arm, and the anterior or lateral areas of
the thighs and abdomen. Avoid the area approximately 2 inches around the navel.
Residents Affected - Some
b. Injection sites should be rotated, preferably within the same general area (abdomen, thigh, upper arm).
During a review of the facility provided Manufacturer's Guideline on the use of Lispro- Injection, last revised
on 8/2024, the guideline indicated to change the injection site each time to lessen injury under the skin (for
example, pits/lumps or thickened skin).
c. During a review of Resident 33's admission Record, the admission Record indicated the facility admitted
the resident on 3/7/2024 with diagnoses including but not limited to type two diabetes mellitus (DM 2 -a
disorder characterized by difficulty on blood sugar control and poor wound healing) and heart failure (a
condition that develops when the heart does not pump enough blood to the body's needs).
During a review of Resident 33's History and Physical (H&P) dated 3/8/2024, the H&P indicated the
resident had the capacity to understand and make decisions.
During a review of Resident 33's Minimum Data Set (MDS, a federally mandated resident assessment tool),
dated 9/10/2024, the MDS indicated the resident had moderately impaired cognition (mental action or
process of acquiring knowledge and understanding) and required set up assistance with eating, and oral
hygiene; supervision or touching assistance with rolling left and right; substantial/maximal assistance from
staff with all other activities of daily living (ADLs - basic tasks that must be accomplished every day for an
individual to thrive). The MDS indicated Resident 33 received insulin.
During a review of Resident 33's Order Summary Report, the Order Summary Report indicated the
following physician's order dated 3/7/2024:
Humalog injection solution (insulin lispro) [a hormone that works by lowering levels of sugar in the blood; a
fast-acting insulin that starts to work about 15 minutes after injection, peaks in about 1 hour, and keeps
working for 2 to 4 hours] inject as per sliding scale: if 150 - 200 = 2 units ( a unit of measurement); 201 250 = 4 units; 251 - 300 = 6 units; 301 - 350 = 8 units; 351 - 400 = 10 units. Call physician for blood sugar
less than (<) 60 or more than (>) 400, subcutaneously (SQ) before meals and at bedtime for DM 2.
During a review of Resident 33's Medication Administration Record (MAR) from 7/2024 to 9/2024, the MAR
indicated Humalog injection solution was administered as follows:
07/03/24 9:00 p.m. 07/03/24 8:12 p.m. SQ Abdomen - left lower quadrant (LLQ)
07/04/24 7:00 a.m. 07/04/24 6:13 a.m. SQ Abdomen - LLQ
07/14/24 5:00 p.m. 07/14/24 4:34 p.m. SQ Abdomen - right upper quadrant (RUQ)
07/14/24 9:00 p.m. 07/14/24 9:02 p.m. SQ Abdomen - RUQ
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
056168
If continuation sheet
Page 34 of 48
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
056168
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
10/03/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Granada Hills Convalescent
16123 Chatsworth Ave
Granada Hills, CA 91344
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0760
07/23/24 9:00 p.m. 07/23/24 8:14 p.m. SQ Abdomen - LLQ
Level of Harm - Minimal harm
or potential for actual harm
07/25/24 5:00 p.m. 07/25/24 4:14 p.m. SQ Abdomen - LLQ
08/16/24 9:00 p.m. 08/16/24 8:32 p.m. SQ Abdomen - LUQ
Residents Affected - Some
08/17/24 7:00 a.m. 08/17/24 6:42 a.m. SQ Abdomen - LUQ
08/21/24 9:00 p.m. 08/21/24 9:35 p.m. s SQ Abdomen - LUQ
08/22/24 7:00 a.m. 08/22/24 6:22 a.m. SQ Abdomen - LUQ
08/29/24 7:00 a.m. 08/29/24 6:38 a.m. SQ Abdomen - LLQ
08/31/24 7:00 a.m. 08/31/24 7:19 a.m. SQ Abdomen - LLQ
During a concurrent interview and record review on 10/3/2024 at 1:30 p.m., with the Director of Nursing
(DON), reviewed Resident 33's physician's orders, MAR, and location of administration sites for Humalog
injection solution from 8/2024 to 9/2024. The DON verified the insulin injection sites were not rotated. The
DON stated the licensed nurses (LN) should have rotated insulin administration sites to prevent
discoloration, swelling, trauma to the skin. The DON stated the LNs should observe the previous site and
then rotate the site for the next dose of insulin, check the site if it is discolored or bruised and monitor the
resident for pain. The DON stated the LNs should clean and disinfect the area, check the correct dose and
route before administering the medication. The DON stated not rotating insulin administration sites is
considered a medication error per the manufacturer's guideline and standards of practice.
During a review of the facility's policy and procedure (P&P) titled, Insulin Administration, last reviewed on
4/12/2024, the P&P indicated a purpose to provide guidelines for the safe administration of insulin to
residents with diabetes. The P&P indicated:
Select an injection site.
a. Insulin may be injected into the subcutaneous tissue of the upper arm, and the anterior or lateral areas of
the thighs and abdomen. Avoid the area approximately 2 inches around the navel.
b. Injection sites should be rotated, preferably within the same general area (abdomen, thigh, upper arm).
During a review of the facility's recent policy and procedure (P&P) titled Adverse Consequences and
Medication Errors, last reviewed on 4/12/2024, the P&P indicated a medication error is defined as the
preparation or administration of drugs or biological which is not in accordance with physician's orders,
manufacturer specifications, or accepted professional standards and principles of the professional(s)
providing services.
During a review of the facility provided manufacturer's guideline for Humalog injection solution, last revised
on 8/2024, the manufacturer's guideline indicated to change the injection site each time to lessen injury
under the skin such as lumps or thickened skin.
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
056168
If continuation sheet
Page 35 of 48
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
056168
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
10/03/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Granada Hills Convalescent
16123 Chatsworth Ave
Granada Hills, CA 91344
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0760
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
d. During a review of Resident 28's admission Record, the admission Record, the admission Record
indicated the facility admitted the resident on 3/4/2021 and readmitted the resident on 7/28/2024 with
diagnoses including but not limited to type two diabetes mellitus (DM 2 - a disorder characterized by
difficulty on blood sugar control and poor wound healing), long term use of insulin, and lack of coordination.
During a review of Resident 28's History and Physical (H&P) dated 7/29/2024, the H&P indicated the
resident had the capacity to understand and make decisions.
During a review of Resident 28's Minimum Data Set (MDS, a federally mandated resident assessment tool),
dated 8/3/2024, the MDS indicated the resident had moderately impaired cognition (mental action or
process of acquiring knowledge and understanding) and required supervision or touching assistance with
eating, and oral hygiene; partial/moderate assistance from staff with all other activities of daily living (ADLs
- basic tasks that must be accomplished every day for an individual to thrive). The MDS indicated Resident
28 received insulin.
During a review of Resident 28's Order Summary Report, the Order Summary Report indicated the
following physician's order dated 7/28/2024:
Lantus subcutaneous (SQ) solution 100 unit per milliliters (unit/ml - a unit of measurement) [insulin glargine
- a long-acting type of insulin that works slowly over about 24 hours used to lower blood sugar in adults and
children with diabetes] inject 18 units subcutaneously (SQ) one time a day for DM 2.
During a review of Resident 28's Medication Administration Record (MAR) from 7/2024 to 9/2024, the MAR
indicated Lantus SQ solution was administered as follows:
07/16/24 9:00 a.m. 07/16/24 9:04 a.m. SQ Abdomen - right upper quadrant (RUQ)
07/17/24 9:00 a.m. 07/17/24 9:21 a.m. SQ Abdomen - RUQ
07/20/24 9:00 a.m. 07/20/24 8:20 a.m. SQ Arm - Upper arm (rear) (left)
07/21/24 9:00 a.m. 07/21/24 8:42 a.m. SQ Arm - Upper arm (rear) (left)
08/18/24 9:00 a.m. 08/18/24 8:59 a.m. SQ Arm - Upper arm (rear) (right)
08/23/24 9:00 a.m. 08/23/24 9:40 a.m. SQ Arm - Upper arm (rear) (right)
09/06/24 9:00 a.m. 09/06/24 9:42 a.m. SQ Arm - Upper arm (rear) (left)
09/07/24 9:00 a.m. 09/07/24 8:43 a.m. SQ Arm - Upper arm (rear) (right)
09/27/24 9:00 a.m. 09/27/24 8:51 a.m. SQ Abdomen - left upper quadrant (LUQ)
09/28/24 9:00 a.m. 09/28/24 9:07 a.m. SQ Abdomen - LUQ
09/29/24 9:00 a.m. 09/29/24 8:37 a.m. SQ Arm - Upper arm (rear) (right)
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
056168
If continuation sheet
Page 36 of 48
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
056168
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
10/03/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Granada Hills Convalescent
16123 Chatsworth Ave
Granada Hills, CA 91344
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0760
09/30/24 9:00 a.m. 09/30/24 8:45 a.m. SQ Arm - Upper arm (rear) (right)
Level of Harm - Minimal harm
or potential for actual harm
During a concurrent interview and record review on 10/3/2024 at 1:30 p.m., with the Director of Nursing
(DON), reviewed Resident 28's physician's orders, MAR, and location of administration sites for Lantus SQ
solution from 7/2024 to 9/2024. The DON verified the insulin injection sites were not rotated. The DON
stated the licensed nurses (LN) should have rotated insulin administration sites to prevent discoloration,
swelling, trauma to the skin. The DON stated the LNs should observe the previous site and then rotate the
site for the next dose of insulin, check the site if it is discolored or bruised and monitor the resident for pain.
The DON stated the LNs should clean and disinfect the area, check the correct dose and route before
administering the medication. The DON stated not rotating insulin administration sites is considered a
medication error per the manufacturer's guideline and standards of practice.
Residents Affected - Some
During a review of the facility's recent policy and procedure (P&P) titled Adverse Consequences and
Medication Errors, last reviewed on 4/12/2024, the P&P indicated a medication error is defined as the
preparation or administration of drugs or biological which is not in accordance with physician's orders,
manufacturer specifications, or accepted professional standards and principles of the professional(s)
providing services.
During a review of the facility's policy and procedure (P&P) titled, Insulin Administration, last reviewed on
4/12/2024, the P&P indicated a purpose to provide guidelines for the safe administration of insulin to
residents with diabetes. The P&P indicated:
Select an injection site.
a. Insulin may be injected into the subcutaneous tissue of the upper arm, and the anterior or lateral areas of
the thighs and abdomen. Avoid the area approximately 2 inches around the navel.
b. Injection sites should be rotated, preferably within the same general area (abdomen, thigh, upper arm).
During a review of the facility provided manufacturer's guideline for insulin glargine - injection, undated, the
manufacturer's guideline indicated to change the injection site each time to lessen injury under the skin
such as lumps or thickened skin.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
056168
If continuation sheet
Page 37 of 48
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
056168
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
10/03/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Granada Hills Convalescent
16123 Chatsworth Ave
Granada Hills, CA 91344
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0761
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Ensure drugs and biologicals used in the facility are labeled in accordance with currently accepted
professional principles; and all drugs and biologicals must be stored in locked compartments, separately
locked, compartments for controlled drugs.
Based on observation, interview, and record review the facility failed to discard nine (9) boxes of BinaxNOW
COVID-19 Antigen Self-Test ( a rapid antigen point-of-care test that can be used to diagnose an active
COVID-19 [an infectious disease caused by the SARS-CoV-2 virus) used on staff and residents with
expiration date of 1/18/2024 stored in the facility's Medication Room observed during medication storage
and labeling facility task.
The deficient practice increased the risk of the resident being misdiagnosed with COVID-19 that leads to
delay in the care and treatment.
Findings:
During a concurrent observation and interview on 10/3/2024, at 9:40 a.m., with Licensed Vocational Nurse
1 (LVN 1), inside the Medication Room, 9 boxes of BinaxNOW COVID-19 Antigen Self-Test with expiration
date of 1/18/2024 was observed. LVN 1 stated they used those self-test kits to test staff and residents for
COVID-19. LVN 1 stated expired medications and test kits should be disposed of after its expiration date to
prevent adverse effects (a harmful or abnormal result) of drugs and false diagnosis to residents and staff.
During a concurrent observation and interview on 10/3/2024, at 2:22 p.m., with the Director of Nursing
(DON), inside the Medication Room, 9 boxes of BinaxNOW COVID-19 Antigen Self-Test with expiration
date of 1/18/2024 was observed. The DON stated there was an extension on the use of the BinaxNOW
COVID-19 Antigen Self-Test and she will double check with her Infection Preventionist (IP) what the real
expiration date of the test kit was. The DON stated BinaxNOW COVID-19 Antigen Self-Test with expiration
date of 1/18/2024 should have been thrown away so that the staff or residents do not get false negative or
false positive result when used for testing.
During an interview on 10/3/2024, at 2:30 p.m., with the IP, the IP stated the BinaxNOW COVID-19 Antigen
Self-Test with expiration date of 1/18/2024 should have been discarded already as it was past its expiration
extension set by Centers for Disease Control and Prevention (CDC, a U.S. federal agency that protects
public health) to prevent erroneous results that could delay care and treatment to residents and staff.
During a review of the facility's recent policy and procedure (P&P) titled Expired Products, last reviewed on
4/12/2024, the P&P indicated staff must regularly check all products for expiration dates during routine
inventory audits and before use. Expired medications, food, and supplies must be immediately segregated
and marked to prevent accidental use. Expired products must be stored in a designated area until proper
disposal can occur. Staff should be trained to recognize and manage expired products appropriately.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
056168
If continuation sheet
Page 38 of 48
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
056168
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
10/03/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Granada Hills Convalescent
16123 Chatsworth Ave
Granada Hills, CA 91344
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0842
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Safeguard resident-identifiable information and/or maintain medical records on each resident that are in
accordance with accepted professional standards.
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
observation, interview, and record review, the facility failed to ensure the order for Restorative Nursing
Assistance (RNA - a type of program in long term care facilities intended to restore lost abilities or maintain
potentially deteriorating functions for residents) program was entered accurately in the electronic health
record (EHR) for one (1) out of 1 sampled resident (Resident 36) during an investigation under the
position/mobility care area.
This deficient practice had the potential for incomplete and inaccurate medical documentation and cause a
delay in provision of necessary care and services Resident 36 needs.
Findings:
During a review of Resident 36's admission Record, the admission Record indicated the facility admitted
the resident on 3/9/2024 and was readmitted on [DATE] with diagnoses that included dementia (a general
term for a condition with loss of memory, language, problem-solving and other thinking abilities that are
severe enough to interfere with daily life), gastrostomy status, and chronic pain syndrome.
During a review of Resident 36's History and Physical (H&P) dated 12/17/2023, the H&P indicated the
resident can make needs known but unable to make medical decisions.
During a review of Resident 36's Minimum Data Set (MDS, a standardized assessment and care screening
tool), dated 7/23/2024, the MDS indicated the resident had severely impaired cognition (mental action or
process of acquiring knowledge and understanding) and was totally dependent on staff with all activities of
daily living (ADLs - basic tasks that must be accomplished every day for an individual to thrive). The MDS
indicated Resident 36 had impairment of both upper and both lower extremities and received feeding thru
the tube.
During a review of Resident 36's Order Summary Report, the Order Summary Report indicated the
following physician orders:
5/9/2024: Restorative Nursing Assistance (RNA - a type of program in long term care facilities intended to
restore lost abilities or maintain potentially deteriorating functions for residents) for passive range of motion
(PROM) exercise program both lower extremities (BLEs) seven (7) times per week daily as tolerated every
day shift.
5/9/2024 and discontinued on 9/25/2024: RNA for PROM of both upper extremities (BUEs) followed by
application of elbow splint daily six (6) per week. Check every two (2) hours for signs and symptoms of skin
breakdown, off Saturdays every day shift Monday, Tuesday, Wednesday, Thursday, Friday, Sunday.
9/25 /2024: RNA for PROM of BUEs followed by application of elbow splint and RUE wrist/hand splint daily
for 6 weeks. Check every 2 hours for skin integrity or redness, off on Saturdays one time a day Monday,
Tuesday, Wednesday, Thursday, Friday, Sunday for 6 weeks. On for up to 4 to 6 hours.
During a review of Resident 36's Restorative Record flowsheet for 9/2024 and 10/2024, the
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
056168
If continuation sheet
Page 39 of 48
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
056168
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
10/03/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Granada Hills Convalescent
16123 Chatsworth Ave
Granada Hills, CA 91344
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0842
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Restorative Record flowsheet indicated Resident 36 was last provided the RNA for PROM of BUEs and
splint application on BUE on 9/25/2024. The Restorative Record flowsheet for 10/2024 indicated Resident
36's RNA program only included PROM exercises of BLEs.
During an observation on 10/1/2024 at 9:20 a.m., 10/3/2024 at 9:30 a.m., and 10/3/2024 at 11:27 a.m.,
inside Resident 31's room, observed resident up on the wheelchair with protective sleeves on both arms
without a splint applied.
During a concurrent interview and record review on 10/3/2024 at 12:04 p.m., Resident 36's physician's
order, and Restorative Record flowsheets for 9/2024 and 10/2024, with Restorative Nursing Assistant 1
(RNA 1), present was reviewed. RNA 1 verified Resident 36 had a physician's order for application of BUE
elbow splint and RUE wrist/hand splint after PROM exercises 6 times per week dated 9/25/2024 but was
not in the flowsheet. RNA 1 stated the application of splint had been on hold for almost one month as the
resident had pain during exercises and was placed on occupational therapy (a type of treatment that assists
patients how to function in their respective roles and how to perform their daily tasks or activities)
treatments. RNA 1 stated she was not aware that the order for application of splint was resumed as she
was not working when it was resumed. RNA 1 stated new RNA orders are communicated to them by the
charge nurse or Director of Rehabilitation (DOR). RNA 1 stated if the application of splint was not provided
to Resident 36 as ordered, it placed the resident for worsening of the contracture.
During a concurrent interview and record review on 10/3/2024 at 12:20 p.m., Resident 36's physician's
order and Restorative Record flowsheet for 9/2024 and 10/2024 was reviewed with the Director of Nursing
(DON). The DON verified Resident 36 had a previous order for application of splint on BUE elbow 6 times
per week discontinued 9/25/2024 and was reentered on 9/25/2024 to include application of splint on the
RUE wrist/hand. The DON verified the Restorative Record flowsheet from 9/26/2024 to 9/30/2024 and
10/2024 did not indicate the new order. The DON stated the charge nurse who entered the order did not
indicate the order type in the electronic health record (EHR), hence the new order did not populate in the
Restorative Record flowsheet. The DON stated the charge nurse should have entered the new order for
application of splints correctly to ensure the RNAs assigned to Resident 36 were aware of the new order to
prevent delay in the provision of care and prevent further contracture. The DON stated it was an order entry
error.
During a review of the facility's policy and procedure (P&P) titled, Physician Orders, last reviewed
4/12/2024, the P&P indicated orders for medications ad treatments will be consistent with principles of safe
and effective order writing.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
056168
If continuation sheet
Page 40 of 48
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
056168
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
10/03/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Granada Hills Convalescent
16123 Chatsworth Ave
Granada Hills, CA 91344
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0880
Provide and implement an infection prevention and control program.
Level of Harm - Minimal harm
or potential for actual harm
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
observation, interview, and record review the facility failed to maintain an infection prevention and control
program designed to provide a safe, sanitary, and comfortable environment and to help prevent the
development and transmission of communicable diseases and infections by failing to ensure:
Residents Affected - Some
1. Resident 15's nasal cannula oxygen tubing (a thin, flexible tube that delivers oxygen to a patient through
two prongs that fit into the nostrils) was labeled with the date it was last changed for one of two sampled
residents investigated under respiratory care.
2. Resident 32's nasal cannula oxygen tubing was off the floor and the nebulizer tubing (a tube that
connects the compressor of a nebulizer to the medication cup) was labeled with the date it was last
changed for one of two residents investigated under respiratory care.
3. The facility discarded two opened enteral feeding kit (a tube that delivers nutrition or hydration into the
stomach or small intestine of a patient who is unable to eat or drink enough) mixed with unopened enteral
feeding kit inside the medication room.
4. Licensed Vocational Nurse 1 (LVN 1) cleaned the glucometer (a small, portable device that measures the
amount of glucose, or blood sugar, in the blood) used on a resident with an antiseptic wipe (a single-use
wipe that contains an antiseptic solution to clean and sterilize wounds and surfaces) prior to returning the
glucometer to the medication cart.
5. The temperature of water in the resident's room were above 113 degrees Fahrenheit (F, a temperature
scale) to prevent the growth of Legionella (a severe form of pneumonia- lung inflammation usually caused
by infection) in the facility's water system.
The deficient practices had a potential to spread infections and illnesses among residents.
Findings:
1. During a review of Resident 15's admission Record (AR), the AR indicated the facility admitted the
resident on 4/2/2024, with diagnoses including chronic obstructive pulmonary disease (COPD, a chronic
lung disease that makes it difficult to breathe by restricting airflow) and dependence on supplemental
oxygen (a medical treatment that provides extra oxygen to people who have trouble breathing or low blood
oxygen levels).
During a review of Resident 15's History and Physical (H&P), dated 4/3/2024, the H&P indicated the
resident had the capacity to understand and make decisions.
During a review of Resident 15's Minimum Data Set (MDS, a standardized assessment and care screening
tool), dated 7/7/2024, the MDS indicated the resident had the ability to make self-understood and
understand others. The MDS indicated the resident was on oxygen therapy (a treatment that provides extra
oxygen to people with breathing problems or lung diseases).
During a review of Resident 15's Order Summary Report, dated 4/3/2024, the report indicated an order for
oxygen (O2) at 2 liters per minute (LPM, a measurement of the velocity at which air flows into the sample
probe) via nasal cannula (NC, a medical device that provides supplemental oxygen or
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
056168
If continuation sheet
Page 41 of 48
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
056168
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
10/03/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Granada Hills Convalescent
16123 Chatsworth Ave
Granada Hills, CA 91344
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0880
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
increased airflow to a patient through the nose), may titrate (evaluates the oxygen needs at rest and at
exercise) to maintain O2 greater than (>) 92%. Every shift.
During an observation on 10/1/2024, at 9:18 a.m., with the Certified Nursing Assistant 4 (CNA 4), inside
Resident 15's room, the oxygen via nasal cannula tubing of the resident was not labeled with the date it
was last changed. CNA 4 stated there was no date on the oxygen tubing and it was supposed to be
changed daily.
During an interview on 10/3/2024, at 1:18 p.m., with the Director of Nursing (DON), the DON stated the
staff should date the oxygen tubing of when it was last changed to know when the oxygen tubing needed to
be replaced for infection control purposes.
During a review of the facility's recent policy and procedure (P&P) titled, Oxygen Tubing Labeling, last
reviewed on 4/12/2024, the P&P indicated appropriate infection prevention and control of oxygen tubing
and supplies are obtained, stored, and used in accordance with current guidelines and manufacturer
instructions. Nurse will ensure all tubing is labeled with the date when using it. Tubing that touches the floor
or any unclean surface will be removed and change with a new tubing.
2. During a review of Resident 32's admission Record (AR), the AR indicated the facility admitted the
resident on 7/25/2022, and readmitted the resident on 9/22/2024, with diagnoses including acute
respiratory failure with hypercapnia (a condition where the lungs have trouble removing carbon dioxide from
the blood, causing a buildup of carbon dioxide in the blood), pleural effusion (a condition where too much
fluid builds up in the space between the lungs and chest wall), and dependence on supplemental oxygen.
During a review of Resident 32's H&P, dated 9/23/2024, the H&P indicated the resident had acute
hypoxemic respiratory failure (a severe condition that occurs when the body does not have enough oxygen
in the blood, but carbon dioxide levels are normal or low). The H&P indicated the resident had the capacity
to make decisions.
During a review of Resident 32's MDS, dated [DATE], the MDS indicated the resident had the ability to
make self-understood and understand others. The MDS indicated the resident was on continuous oxygen
therapy.
During a review of Resident 32's Order Summary Report, the report indicated an order for:
9/22/2024 O2 at 2-3 LPM via NC, may titrate to maintain O2 >92%. Every shift.
10/1/2024 Budesonide inhalation suspension 0.5 milligrams (mg, a unit of weight)/2 milliliters (ml, a unit of
volume) (Budesonide Inhalation). 2 ml inhale orally two times a day for anti-asthmatic (a medication or drug
that helps treat asthma by relieving symptoms and improving breathing). Rinse mouth after each use and
spit out.
9/22/2024 DuoNeb (Ipratropium-Albuterol 0.5-3 mg/ 3 ml Amp). 1 application inhale orally every 6 hours for
shortness of breath (SOB)/wheezing (a high-pitched, whistling sound that can occur during breathing when
airways in the lungs become narrowed or blocked). Administer for at least 15 minutes via nebulizer (an
electrically powered machine that turns liquid medication into a mist so that it can be breathed directly into
the lungs through a face mask or mouthpiece).
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
056168
If continuation sheet
Page 42 of 48
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
056168
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
10/03/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Granada Hills Convalescent
16123 Chatsworth Ave
Granada Hills, CA 91344
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0880
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
During a review of Resident 32's Care Plan titled Respiratory risk related to COPD, acute hypoxemic
hypercapnia respiratory failure, last revised on 9/27/2024, the CP indicated an intervention of appropriate
equipment at bedside for emergency use, breathing treatment as ordered, and medication as ordered:
Budesonide, DuoNeb.
During a concurrent observation and interview on 10/1/2024, at 3:35 p.m., with the Infection Preventionist
(IP), observed Resident 32's oxygen via nasal cannula tubing was on the floor. The IP stated the oxygen
tubing should be off the floor and if the tubing was on the floor, it should have been replaced with a new
one to prevent infection to residents. The IP also stated the nebulizer tubing should be dated with the day it
was last changed to know when to change them again to prevent infection to residents.
During an interview on 10/3/2024, at 1:20 p.m., with the DON, the DON stated the staff should keep the
oxygen tubing off the floor and when seen touching the floor, it should be replaced immediately for infection
control. The DON also stated the nebulizer tubing should be dated with the date it was last changed to
know when to change them again and for infection control purposes.
During a review of the facility's recent policy and procedure (P&P) titled, Oxygen Tubing Labeling, last
reviewed on 4/12/2024, the P&P indicated appropriate infection prevention and control of oxygen tubing
and supplies are obtained, stored, and used in accordance with current guidelines and manufacturer
instructions. Nurse will ensure all tubing is labeled with the date when using it. Tubing that touches the floor
or any unclean surface will be removed and change with a new tubing.
During a review of the facility's recent policy and procedure (P&P) titled, Administering Medications through
a Small Volume (Handheld) Nebulizer, last reviewed on 4/12/2024, the P&P indicated after attaching the
tubing to the source gas, label the tubing with the date. Change equipment and tubing every seven days, or
according to facility protocol.
3. During a concurrent observation and interview on 10/3/2024, at 9:40 a.m., with LVN 1, inside the
Medication Room, two opened enteral feeding kit mixed with unopened enteral kits inside the Medication
Room was observed. LVN 1 stated the opened enteral kits should have been discarded to prevent infection
to residents.
During an interview on 10/3/2024, at 2:22 p.m., with the DON, the DON stated the staff should have
disposed the opened enteral kit to prevent infection to residents.
During a review of the facility's recent policy and procedure (P&P) titled Enteral Feedings- Safety
Precautions, last reviewed on 4/12/2024, the P&P indicated to maintain strict aseptic techniques at all times
when working with enteral nutrition systems and formulas.
4. During a concurrent observation and interview on 10/2/2024, at 11:48 a.m., with LVN 1, LVN 1 was
observed performing a finger stick blood sugar (FSBS, is a method for monitoring blood glucose levels) on
a resident and returned the glucometer back to the medication cart without wiping the glucometer with an
antiseptic wipe. LVN 1 stated he should have wiped the glucometer with an antiseptic wipe to prevent
infection among residents.
During an interview on 10/3/2024, at 1:44 p.m., with the DON, the DON stated the licensed staff should
clean the glucometer before and after in between patient use to prevent blood borne diseases from
spreading.
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
056168
If continuation sheet
Page 43 of 48
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
056168
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
10/03/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Granada Hills Convalescent
16123 Chatsworth Ave
Granada Hills, CA 91344
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0880
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
During A review of the facility's recent policy and procedure (P&P) titled, Obtaining a Fingerstick Glucose
Level, Glucometers, Cleaning and Storage, last reviewed on 4/12/2024, the P&P indicated to always ensure
that blood glucose meters intended for reuse are cleaned and disinfected between resident uses.
5. During a concurrent interview and record review on 10/2/2024, at 3:24 p.m., with the Administrator
(ADM), Maintenance Supervisor (MS), and Maintenance Consultant (MC), the ADM stated the Water
Management Committee meets monthly and they do maintenance rounds. The ADM stated they follow the
Centers for Disease Control and Prevention (CDC, a U.S. federal agency that protects public health)
guidance on preventing Legionella in their water system. The ADM stated they keep the water temperature
in the facility above 113 degrees F to prevent Legionella in the facility. Reviewed the facility's Water
Temperature Log for 9/2024. The waterlog indicated a random room water temperature measurement from
9/1/2024 to 9/30/2024 with consistent 109 degrees F readings. The ADM acknowledges the Water
Temperature Logs with temperatures below 113 degrees F and stated the failure to keep the water
temperature above 113 degrees F predisposes the facility's water system to develop Legionella.
During a concurrent interview and record review on 10/3/2024, at 1:45 p.m., with the DON, the DON stated
the whole 9/2024 Water Temperature Log indicated a temperature of 109 degrees F which predisposed the
facility water system to developing Legionella.
During a review of Water Management Program, last reviewed on 4/12/2024, the program indicated Title 22
(is a set of rules and regulations that govern community care facilities in California) indicated resident water
temperatures for hot water should be between 105 and 120 degrees. Centers for Medicare and Medicaid
Services (CMS, a federal agency that provides health coverage to millions of Americans) states
temperature should be below 120 degrees. Temperatures between 77 F and 113 F are best to grow
Legionella. Legionella tends to grow slower at temperatures under 68 F and begin to die at temperatures
between 113 F and 120 F. Preferably Hot to be above water above 113 F.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
056168
If continuation sheet
Page 44 of 48
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
056168
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
10/03/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Granada Hills Convalescent
16123 Chatsworth Ave
Granada Hills, CA 91344
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0912
Level of Harm - Potential for
minimal harm
Residents Affected - Some
Provide rooms that are at least 80 square feet per resident in multiple rooms and 100 square feet for single
resident rooms.
Based on observation, interview and record review, the facility failed to ensure that 19 of 21 resident rooms
(Rooms 2, 3, 4, 5, 6, 7, 8, 10, 11, 12, 14, 15, 16, 18, 19, 20, 21, 22, and 17) met the square footage
requirement of 80 square feet (sq. ft., a unit of measurement) per resident in multiple resident rooms.
The room size for these rooms had the potential to have inadequate space for resident care and mobility.
Findings:
During the recertification survey from 10/1/2024 to 10/3/2024, it was observed that the residents residing in
the rooms with an application for variance had sufficient amount of space for residents to move freely inside
the rooms. There was adequate room for the operation and use of wheelchairs, walkers, or canes. The
room variance did not affect the care and services provided by nursing staff for the residents.
On 10/1/2024, the Administrator submitted the application for the Room Variance Waiver for 19 resident
rooms. The room variance letter indicated that these rooms did not meet the 80 square feet per resident
requirement per federal regulation. The room waiver request showed the following:
Room #
Square Footage
Number of Beds
2
138.6
2
3
149.6
2
4
149.6
2
5
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
056168
If continuation sheet
Page 45 of 48
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
056168
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
10/03/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Granada Hills Convalescent
16123 Chatsworth Ave
Granada Hills, CA 91344
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0912
138.6
Level of Harm - Potential for
minimal harm
2
6
Residents Affected - Some
149.6
2
7
149.6
2
8
149.6
2
10
149.6
2
11
149.6
2
12
149.6
2
14
149.6
2
15
149.6
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
056168
If continuation sheet
Page 46 of 48
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
056168
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
10/03/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Granada Hills Convalescent
16123 Chatsworth Ave
Granada Hills, CA 91344
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0912
2
Level of Harm - Potential for
minimal harm
16
149.6
Residents Affected - Some
2
18
149.6
2
19
149.6
2
20
149.6
2
21
149.6
2
22
277.2
4
17
277.2
4
The minimum requirement for a 2 bedroom should be at least 160 sq. ft.
The minimum requirement for a 3 bedroom should be at least 240 sq. ft.
The minimum requirement for a 4 bedroom should be at least 320 sq. ft.
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
056168
If continuation sheet
Page 47 of 48
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
056168
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
10/03/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Granada Hills Convalescent
16123 Chatsworth Ave
Granada Hills, CA 91344
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0912
Level of Harm - Potential for
minimal harm
Residents Affected - Some
During the Resident Council Meeting on 10/1/2024, at 2:10 p.m., when the residents were asked about
their room space, there were no concerns or issues brought up.
During a concurrent observation and interview on 10/3/2024, at 9:32 a.m., with Certified Nursing Assistant
1 (CNA 1), inside Resident 32's room, a portable heating, ventilation, and air condition (HVAC, is a system
that controls the temperature, humidity, and air quality of indoor spaces) vented to the window of the
resident was observed. CNA 1 verified the presence of the portable HVAC and stated it takes up the space
of the resident inside the room. Resident 32 stated he does not use the portable HVAC and it is crowding
his room. Resident 32 added that he did not request the HVAC.
During an interview on 10/3/2024, at 12:25 p.m., with Certified Nursing Assistant 3 (CNA 3), CNA 3 stated
she had no issues performing her job as a CNA on rooms with multiple residents.
During an interview on 10/3/2024, at 12:27 p.m., with Licensed Vocational Nurse 3 (LVN 3), LVN 3 stated
she does not have any issues with the space in the rooms with multiple residents. LVN 3 also stated she
has not received any complaints from residents regarding the space in the rooms.
A review of the room waiver letter, undated, the waiver indicated, There is enough space to provide for each
resident care, dignity, and privacy. The rooms are in accordance with the special needs of the resident and
would not have an adverse effect on the resident's health and safety or impede the ability of any resident in
the rooms to attain his or her highest practicable well-being.
A review of the facility's recent policy and procedure (P&P) titled, Bedrooms, last reviewed on 7/2023, the
P&P indicated all residents are provided with clean, comfortable, and safe bedrooms that meet federal and
state requirements. Bedrooms accommodate no more than two residents at a time. Bedrooms measure at
least 80 square feet of space per resident in double rooms, and at least 100 square feet of space in single
rooms. (Note: Individual variations on this may be permitted by federal authorities if it is demonstrated that
the variation is in accordance with special needs of the resident and will not adversely affect the resident's
health and safety.
A review of the facility's recent policy and procedure (P&P) titled, Room Size Standards, last reviewed on
4/12/2024, the P&P indicated room size standards will be at least 80 square feet.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
056168
If continuation sheet
Page 48 of 48